≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of testis

DOID Endpoint Browser

C3_TESTIS

testicular carcinoma: A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

only males

226725

2. Check conditions

None

226725

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C62
  • Cause of death: ICD-9 — 186
  • Cause of death: ICD-8 — 186
  • Cancer registry: Topography ICD-O-3 — C62
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

656

4. Check minimum number of events

None

656

5. Include endpoints

None

656

6. Filter based on genotype QC (FinnGen only)

620

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 620 - 620
Unadjusted period prevalence (%) 0.28 - 0.28
Median age at first event (years) 36.03 - 36.03

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
656
Matched controls
6560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JN4BD
NOMESCO Finland
Extensive body CT
33.4
307.7
253
121
KFC00
NOMESCO Finland
Unilateral orchiectomy
1033.6
307.7
478
17
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
681.8
307.7
400
15
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
303.4
267
*
A03FA01
ATC
metoclopramide; systemic, rectal
18.0
271.4
266
239
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
259.1
231
*
130
Kela drug reimbursment
Malignant tumour
+∞
244.5
219
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
17.7
212.0
195
153
JN4AD
NOMESCO Finland
Body CT examination
17.2
204.9
191
153
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
186.6
170
*
H02AB02
ATC
dexamethasone; systemic
50.9
182.6
107
25
A04AA01
ATC
ondansetron; systemic, rectal
32.6
161.2
107
39
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
138.6
128
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
110.6
103
*
A04AA02
ATC
granisetron; systemic, transdermal
1148.0
103.1
98
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
100.7
94
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
177.9
89.7
92
6
121
Kela drug reimbursment
Severe hypofunction of sexual glands
30.8
88.6
59
21
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
85.3
80
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
85.3
80
*
L03AA02
ATC
filgrastim; parenteral
187.0
80.1
82
5
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
78.8
74
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
75.5
71
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
67.8
403
1848
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
65.7
62
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
62.5
59
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
167.8
59.0
61
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.7
58.1
302
1236
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
57.1
54
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.9
56.9
115
229
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
56.0
53
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
584.9
55.4
54
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
53.6
147
380
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
51.8
49
*
L03AA13
ATC
pegfilgrastim; parenteral
537.7
51.2
50
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.8
50.1
73
103
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
47.5
45
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
47.5
45
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
491.1
46.9
46
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
44.3
42
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
44.3
42
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
433.7
41.6
41
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
41.1
39
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
422.3
40.6
40
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
40.0
38
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
40.0
38
*
N02AA05
ATC
oxycodone; systemic
4.3
39.8
117
315
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
38.9
37
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
37.9
36
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.2
37.2
114
316
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
37.0
204
827
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
36.8
35
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
36.8
35
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
51.0
36.1
43
9
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
35.8
34
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
35.4
121
362
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
33.6
32
*
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
33.6
32
*
ZXE00
NOMESCO Finland
One hour or less
2.7
32.8
264
1300
Z51.5
ICD-10 Finland
Palliative care
7.6
32.2
47
66
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.7
31.7
46
64
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
31.5
30
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
327.8
31.1
31
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
167.9
31.0
32
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
30.4
29
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
30.4
29
*
WW500
NOMESCO Finland
Blood transfusion
10.2
29.7
34
35
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
29.4
28
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
29.4
28
*
Y05
ICPC
Scrotum/testis sympt/compl other
7.5
28.7
42
59
E29.1
ICD-10 Finland
Testicular hypofunction
6.0
28.3
52
93
WX402
NOMESCO Finland
General anaesthesia
2.8
26.9
166
703
WX320
NOMESCO Finland
Spinalanesthesy
2.8
25.6
156
654
B01AB10
ATC
tinzaparin; parenteral
4.3
25.4
69
173
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
25.2
24
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
4.9
25.0
57
124
Y78
ICPC
Malign neopl male genital other
+∞
24.1
23
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
24.1
23
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
23.3
223
1156
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.6
23.1
45
85
L01BC06
ATC
capecitabine; oral
+∞
23.1
22
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
23.1
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
238.0
22.8
23
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
22.5
87
279
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.6
22.0
36
57
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
22.0
21
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
22.0
21
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
22.0
21
*
DFF00
NOMESCO Finland
Pure tone audiometry
3.4
21.5
83
266
JN4CD
NOMESCO Finland
Very extensive body CT
17.6
20.7
32
19
XW000
NOMESCO Finland
Bone marrow biopsy
8.1
20.6
28
36
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
8.7
20.3
26
31
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
19.9
19
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
19.4
57
151
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
19.4
216
1179
B01AB05
ATC
enoxaparin; parenteral
2.4
19.2
156
744
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
18.8
18
*
116
Kela drug reimbursment
Prostate cancer
+∞
18.8
18
*
WZC30
NOMESCO Finland
Teaching
2.8
18.8
108
434
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.8
18.7
107
429
D29.2
ICD-10 Finland
Benign neoplasm: Testis
39.7
18.7
23
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.7
18.4
26
35
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
17.8
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.8
17
*
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
17.8
17
*
ZX120
NOMESCO Finland
Intravenous
3.6
17.7
62
186
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.7
16
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.7
16
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
16.7
16
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.7
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.5
16.6
24
33
KF8AE, ,
SPAT
4.9
16.5
37
79
N02BE01
ATC
paracetamol; systemic, rectal
2.5
16.2
556
4530
N46
ICD-10 Finland
Male infertility
4.2
15.9
43
107
N50.9
ICD-10 Finland
Disorder of male genital organs, unspecified
7.4
15.8
23
32
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
15.7
15
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
15.7
15
*
JN6AD
NOMESCO Finland
CT of torso and neck
22.7
15.6
22
10
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.4
15.6
26
42
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
82.0
14.6
16
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
54.6
13.9
16
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
13.6
13
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
142.8
13.5
14
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
13.4
105
487
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
12.5
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.5
12
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
12.5
12
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
12.5
12
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
12.3
66
255
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
12.2
26
53
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
12.2
64
244
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
12.1
110
543
R50.9
ICD-10 Finland
Fever, unspecified
2.2
11.9
111
554
ZX090
NOMESCO Finland
Other technic of radiotherapy
66.2
11.6
13
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
11.5
11
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
11.5
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.5
11
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
11.5
11
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
11.3
42
131
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
11.2
135
742
B01AB04
ATC
dalteparin; parenteral
4.4
10.9
27
63
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.8
115
602
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.5
10.8
26
59
WX702
NOMESCO Finland
Supraglottic ventilation device
3.2
10.7
43
141
7513
FHL
Test prosthesis installation
61.0
10.7
12
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
10.4
10
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.4
10
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
10.4
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.4
10
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
33.1
10.4
13
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.7
10.3
33
93
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
4.6
10.1
24
54
KFA00
NOMESCO Finland
Exploration of testis
8.9
9.8
20
23
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
9.8
42
143
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
9.8
28
73
M04AA01
ATC
allopurinol; systemic
2.2
9.7
82
392
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
9.4
32
94
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
9.4
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
9.4
9
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
9.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
ZXA05
NOMESCO Finland
Left side
1.9
9.4
128
731
A02BC02
ATC
pantoprazole; systemic
1.7
9.1
373
2901
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.2
9.1
18
20
J01MA12
ATC
levofloxacin; systemic
2.1
9.1
96
501
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
37.2
9.0
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.7
239
1674
R4190
NOMESCO Finland
Nutritional therapy
3.9
8.6
25
66
KA1FN
NOMESCO Finland
Isotope renography
16.6
8.6
13
8
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
91.2
8.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.3
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.3
8
*
Y77
ICPC
Malignant neoplasm prostate
+∞
8.3
8
*
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
8.3
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
8.3
8
*
Y28
ICPC
Limited function/disability (Y)
9.6
8.3
16
17
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
8.3
38
135
R4110
NOMESCO Finland
Physiotherapy
1.8
8.2
145
896
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
8.1
60
270
KFB00
NOMESCO Finland
Biopsy of testis
17.4
8.1
12
7
ZXA00
NOMESCO Finland
Right side
1.8
8.0
132
798
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
13.2
7.9
13
10
Z31.8
ICD-10 Finland
Other procreative management
45.5
7.7
9
*
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.4
165
1085
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
11.0
7.3
13
12
C03CA01
ATC
furosemide; systemic
1.8
7.3
125
763
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
7.3
7
*
KFC96
NOMESCO Finland
Other total excision of testis or epididymis
+∞
7.3
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
7.2
46
194
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.1
7.0
16
23
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
40.5
6.8
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.7
93
532
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.5
6.7
16
25
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
6.7
50
227
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
6.6
39
159
A02BX02
ATC
sucralfate; oral
4.0
6.5
18
46
JAH01
NOMESCO Finland
Laparoscopy
4.1
6.4
17
42
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
1860A
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOPL MAL TESTIS (ABDOMIN/INGUIN),SEMINOMA]
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
1869C
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),MUU TAI TARK MÄÄRITT]
+∞
6.3
6
*
9680/3-C62.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of descended testis
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
6.3
6
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.4
6.2
17
32
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
6.1
25
83
WX892
NOMESCO Finland
Monitored bed care
2.2
6.1
49
229

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Urology
34 [38004474]
4.6e-01
1.8e+00
6.5e+00
1.0e+50
6.5e+00
3.0e+00
1.4e+00
cases:6.02%
controls:3.90%
cases:8.19%
controls:1.43%
cases:56.69%
controls:0.20%
cases:41.64%
controls:0.00%
cases:35.85%
controls:0.08%
cases:26.06%
controls:1.66%
cases:19.52%
controls:5.46%
36
232
562
5710
49
85
549
5857
339
12
259
5930
249
0
349
5942
214
5
383
5937
154
98
437
5816
105
301
433
5211
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
—
2.9e+00
—
1.0e+50
1.0e+50
6.1e+00
5.9e+00
—
—
cases:1.84%
controls:0.10%
—
—
cases:1.67%
controls:0.00%
cases:19.43%
controls:0.00%
cases:34.86%
controls:0.12%
cases:43.31%
controls:0.20%
—
11
6
587
5936
—
10
0
588
5942
116
0
481
5942
206
7
385
5907
233
11
305
5501
Outpatient Visit
OP [9202]
-2.7e-01
-8.2e-02
2.0e+00
4.4e+00
2.4e+00
1.9e+00
1.3e+00
cases:48.49%
controls:55.12%
cases:31.94%
controls:33.74%
cases:37.96%
controls:7.37%
cases:23.75%
controls:0.37%
cases:47.74%
controls:7.32%
cases:78.85%
controls:35.27%
cases:87.36%
controls:65.04%
290
3275
308
2667
191
2005
407
3937
227
438
371
5504
142
22
456
5920
285
435
312
5507
466
2086
125
3828
470
3585
68
1927
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
-2.1e-01
—
4.7e+00
—
4.4e+00
2.3e+00
7.0e-01
cases:1.34%
controls:1.65%
—
—
cases:11.87%
controls:0.12%
—
—
cases:7.37%
controls:0.10%
cases:6.77%
controls:0.71%
cases:4.83%
controls:2.47%
8
98
590
5844
—
71
7
527
5935
—
44
6
553
5936
40
42
551
5872
26
136
512
5376
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
-2.4e-01
-8.5e-02
2.7e+00
3.3e+00
2.8e+00
1.6e+00
8.6e-01
cases:11.71%
controls:14.44%
cases:11.54%
controls:12.44%
cases:23.58%
controls:2.07%
cases:3.01%
controls:0.12%
cases:26.47%
controls:2.15%
cases:42.47%
controls:13.12%
cases:51.49%
controls:31.02%
70
858
528
5084
69
739
529
5203
141
123
457
5819
18
7
580
5935
158
128
439
5814
251
776
340
5138
277
1710
261
3802
Treatment plan or consultation
WZC00 [2001310885]
-3.3e-02
5.8e-01
2.5e+00
—
4.4e+00
3.1e+00
1.2e+00
cases:3.85%
controls:3.97%
cases:2.17%
controls:1.23%
cases:2.17%
controls:0.19%
—
—
cases:10.89%
controls:0.15%
cases:21.49%
controls:1.20%
cases:12.64%
controls:4.32%
23
236
575
5706
13
73
585
5869
13
11
585
5931
—
65
9
532
5933
127
71
464
5843
68
238
470
5274
General Surgery
2 [38004447]
-1.1e-01
6.7e-01
3.7e+00
1.0e+50
4.4e+00
1.7e+00
5.5e-01
cases:12.71%
controls:13.93%
cases:7.36%
controls:3.90%
cases:17.89%
controls:0.52%
cases:2.68%
controls:0.00%
cases:18.76%
controls:0.29%
cases:15.74%
controls:3.18%
cases:17.10%
controls:10.63%
76
828
522
5114
44
232
554
5710
107
31
491
5911
16
0
582
5942
112
17
485
5925
93
188
498
5726
92
586
446
4926
Ultrasound examination of scrotum
KF8AE [2001306187]
—
3.5e+00
—
1.0e+50
1.0e+50
4.2e+00
3.3e+00
—
—
cases:3.18%
controls:0.10%
—
—
cases:1.51%
controls:0.00%
cases:3.18%
controls:0.00%
cases:6.26%
controls:0.10%
cases:9.67%
controls:0.38%
—
19
6
579
5936
—
9
0
589
5942
19
0
578
5942
37
6
554
5908
52
21
486
5491
Obstetrics / Gynecology
16 [38004461]
-8.0e-02
—
3.9e+00
—
4.3e+00
1.7e+00
1.1e+00
cases:1.34%
controls:1.45%
—
—
cases:4.18%
controls:0.08%
—
—
cases:5.70%
controls:0.08%
cases:2.88%
controls:0.56%
cases:3.72%
controls:1.25%
8
86
590
5856
—
25
5
573
5937
—
34
5
563
5937
17
33
574
5881
20
69
518
5443
Outpatient Hospital
22 [8756]
-6.3e-02
3.4e-01
3.6e+00
—
4.2e+00
2.2e+00
7.5e-01
cases:14.05%
controls:14.83%
cases:6.69%
controls:4.85%
cases:20.90%
controls:0.69%
—
—
cases:25.13%
controls:0.52%
cases:28.09%
controls:4.02%
cases:18.77%
controls:9.87%
84
881
514
5061
40
288
558
5654
125
41
473
5901
—
150
31
447
5911
166
238
425
5676
101
544
437
4968
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
8.6e-01
2.0e+00
—
—
—
5.0e+00
3.7e+00
cases:1.34%
controls:0.57%
cases:2.84%
controls:0.40%
—
—
—
—
—
—
cases:28.76%
controls:0.27%
cases:33.46%
controls:1.22%
8
34
590
5908
17
24
581
5918
—
—
—
170
16
421
5898
180
67
358
5445
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
-2.5e-01
-4.0e-01
4.5e+00
—
4.1e+00
2.1e+00
5.9e-01
cases:2.01%
controls:2.56%
cases:0.84%
controls:1.25%
cases:11.71%
controls:0.15%
—
—
cases:7.20%
controls:0.13%
cases:7.78%
controls:0.98%
cases:6.51%
controls:3.72%
12
152
586
5790
5
74
593
5868
70
9
528
5933
—
43
8
554
5934
46
58
545
5856
35
205
503
5307
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
-1.4e-01
7.6e-01
3.5e+00
—
4.0e+00
2.4e+00
6.2e-01
cases:2.01%
controls:2.31%
cases:3.01%
controls:1.43%
cases:7.02%
controls:0.22%
—
—
cases:7.54%
controls:0.15%
cases:11.84%
controls:1.15%
cases:7.81%
controls:4.34%
12
137
586
5805
18
85
580
5857
42
13
556
5929
—
45
9
552
5933
70
68
521
5846
42
239
496
5273
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
-2.8e-01
2.7e-01
4.9e+00
—
3.1e+00
2.0e+00
5.3e-01
cases:2.84%
controls:3.74%
cases:2.68%
controls:2.05%
cases:19.40%
controls:0.19%
—
—
cases:3.35%
controls:0.15%
cases:9.31%
controls:1.35%
cases:9.48%
controls:5.79%
17
222
581
5720
16
122
582
5820
116
11
482
5931
—
20
9
577
5933
55
80
536
5834
51
319
487
5193
Bacteria [Presence] in Urine
87829-8 [36304419]
-1.4e-01
7.1e-01
3.5e+00
—
3.9e+00
2.4e+00
7.1e-01
cases:2.01%
controls:2.31%
cases:2.84%
controls:1.41%
cases:7.02%
controls:0.22%
—
—
cases:7.37%
controls:0.17%
cases:11.68%
controls:1.17%
cases:7.81%
controls:3.99%
12
137
586
5805
17
84
581
5858
42
13
556
5929
—
44
10
553
5932
69
69
522
5845
42
220
496
5292
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
-1.5e-01
-1.6e-02
2.1e+00
—
3.9e+00
2.8e+00
1.5e+00
cases:4.85%
controls:5.57%
cases:3.51%
controls:3.57%
cases:3.34%
controls:0.40%
—
—
cases:20.10%
controls:0.49%
cases:35.36%
controls:3.15%
cases:33.27%
controls:9.58%
29
331
569
5611
21
212
577
5730
20
24
578
5918
—
120
29
477
5913
209
186
382
5728
179
528
359
4984
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-3.1e-01
-1.4e-01
2.6e+00
2.8e+00
2.8e+00
1.4e+00
6.6e-01
cases:19.06%
controls:24.28%
cases:17.06%
controls:19.13%
cases:32.78%
controls:3.53%
cases:4.01%
controls:0.25%
cases:35.51%
controls:3.38%
cases:49.92%
controls:19.19%
cases:58.36%
controls:41.94%
114
1443
484
4499
102
1137
496
4805
196
210
402
5732
24
15
574
5927
212
201
385
5741
295
1135
296
4779
314
2312
224
3200
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-3.0e-01
-1.9e-01
2.5e+00
3.3e+00
2.5e+00
1.2e+00
6.0e-01
cases:12.88%
controls:16.66%
cases:11.71%
controls:13.77%
cases:26.42%
controls:2.79%
cases:3.68%
controls:0.13%
cases:24.96%
controls:2.78%
cases:35.53%
controls:13.73%
cases:44.61%
controls:30.68%
77
990
521
4952
70
818
528
5124
158
166
440
5776
22
8
576
5934
149
165
448
5777
210
812
381
5102
240
1691
298
3821
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
-9.8e-02
7.9e-01
3.5e+00
—
3.7e+00
2.3e+00
5.6e-01
cases:2.51%
controls:2.76%
cases:3.51%
controls:1.63%
cases:8.03%
controls:0.25%
—
—
cases:7.54%
controls:0.20%
cases:12.35%
controls:1.34%
cases:9.11%
controls:5.41%
15
164
583
5778
21
97
577
5845
48
15
550
5927
—
45
12
552
5930
73
79
518
5835
49
298
489
5214
Inpatient Visit
IP [9201]
1.9e-01
4.1e-02
3.0e+00
1.0e+50
4.4e+00
2.7e+00
5.3e-01
cases:5.52%
controls:4.63%
cases:1.84%
controls:1.77%
cases:4.68%
controls:0.24%
cases:14.55%
controls:0.00%
cases:10.55%
controls:0.15%
cases:21.15%
controls:1.78%
cases:8.92%
controls:5.46%
33
275
565
5667
11
105
587
5837
28
14
570
5928
87
0
511
5942
63
9
534
5933
125
105
466
5809
48
301
490
5211
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
-1.7e-01
3.0e-01
3.3e+00
1.0e+50
3.8e+00
2.1e+00
7.4e-01
cases:2.68%
controls:3.15%
cases:2.51%
controls:1.87%
cases:6.19%
controls:0.24%
cases:1.51%
controls:0.00%
cases:8.88%
controls:0.22%
cases:9.98%
controls:1.35%
cases:8.18%
controls:4.06%
16
187
582
5755
15
111
583
5831
37
14
561
5928
9
0
589
5942
53
13
544
5929
59
80
532
5834
44
224
494
5288
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
-1.1e-01
1.0e-01
3.5e+00
—
3.0e+00
2.3e+00
9.4e-01
cases:1.51%
controls:1.68%
cases:1.00%
controls:0.91%
cases:2.84%
controls:0.08%
—
—
cases:1.68%
controls:0.08%
cases:7.11%
controls:0.73%
cases:6.32%
controls:2.56%
9
100
589
5842
6
54
592
5888
17
5
581
5937
—
10
5
587
5937
42
43
549
5871
34
141
504
5371
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
-5.4e-01
-4.5e-01
4.2e+00
—
3.7e+00
1.9e+00
5.9e-01
cases:1.67%
controls:2.84%
cases:1.00%
controls:1.57%
cases:11.37%
controls:0.19%
—
—
cases:7.20%
controls:0.19%
cases:7.11%
controls:1.18%
cases:6.13%
controls:3.50%
10
169
588
5773
6
93
592
5849
68
11
530
5931
—
43
11
554
5931
42
70
549
5844
33
193
505
5319
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
7.9e-03
2.1e-01
1.6e+00
4.1e+00
3.2e+00
7.6e-01
2.1e-01
cases:21.40%
controls:21.27%
cases:11.04%
controls:9.16%
cases:6.52%
controls:1.38%
cases:4.68%
controls:0.08%
cases:25.13%
controls:1.38%
cases:18.27%
controls:9.49%
cases:30.30%
controls:26.12%
128
1264
470
4678
66
544
532
5398
39
82
559
5860
28
5
570
5937
150
82
447
5860
108
561
483
5353
163
1440
375
4072
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
-2.7e-01
-1.4e-01
1.9e+00
—
4.1e+00
2.5e+00
9.6e-01
cases:2.34%
controls:3.05%
cases:1.51%
controls:1.73%
cases:1.17%
controls:0.19%
—
—
cases:12.56%
controls:0.24%
cases:15.23%
controls:1.42%
cases:10.97%
controls:4.50%
14
181
584
5761
9
103
589
5839
7
11
591
5931
—
75
14
522
5928
90
84
501
5830
59
248
479
5264
CBC panel - Blood by Automated count
58410-2 [40761511]
-2.3e-01
-2.5e-02
2.6e+00
2.8e+00
2.0e+00
1.4e+00
6.2e-01
cases:18.56%
controls:22.33%
cases:14.72%
controls:15.03%
cases:25.42%
controls:2.51%
cases:2.51%
controls:0.15%
cases:17.09%
controls:2.64%
cases:40.61%
controls:14.91%
cases:50.37%
controls:35.36%
111
1327
487
4615
88
893
510
5049
152
149
446
5793
15
9
583
5933
102
157
495
5785
240
882
351
5032
271
1949
267
3563
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-2.9e-01
-1.0e-01
2.7e+00
2.9e+00
2.6e+00
1.1e+00
2.6e-01
cases:15.89%
controls:20.23%
cases:14.05%
controls:15.35%
cases:27.93%
controls:2.54%
cases:3.68%
controls:0.22%
cases:27.30%
controls:2.59%
cases:35.36%
controls:15.44%
cases:40.15%
controls:34.18%
95
1202
503
4740
84
912
514
5030
167
151
431
5791
22
13
576
5929
163
154
434
5788
209
913
382
5001
216
1884
322
3628
Platelets [#/volume] in Blood
26515-7 [3007461]
-2.0e-01
-1.4e-01
2.4e+00
2.8e+00
2.4e+00
1.3e+00
4.6e-01
cases:24.41%
controls:28.39%
cases:20.07%
controls:22.35%
cases:33.78%
controls:4.41%
cases:4.35%
controls:0.29%
cases:32.83%
controls:4.26%
cases:50.76%
controls:22.34%
cases:58.36%
controls:46.90%
146
1687
452
4255
120
1328
478
4614
202
262
396
5680
26
17
572
5925
196
253
401
5689
300
1321
291
4593
314
2585
224
2927
Laboratory Visit
OMOP4822461 [32036]
-2.1e-01
-2.3e-02
2.1e+00
4.4e+00
2.0e+00
7.5e-01
2.0e-01
cases:30.43%
controls:35.02%
cases:30.60%
controls:31.10%
cases:42.98%
controls:8.20%
cases:34.11%
controls:0.66%
cases:40.87%
controls:8.26%
cases:51.61%
controls:33.43%
cases:60.04%
controls:55.21%
182
2081
416
3861
183
1848
415
4094
257
487
341
5455
204
39
394
5903
244
491
353
5451
305
1977
286
3937
323
3043
215
2469
Leukocytes [#/volume] in Urine
30405-5 [3018095]
-1.7e-01
7.1e-01
3.5e+00
—
3.5e+00
2.3e+00
4.4e-01
cases:2.51%
controls:2.95%
cases:3.51%
controls:1.75%
cases:8.03%
controls:0.27%
—
—
cases:7.54%
controls:0.24%
cases:12.52%
controls:1.47%
cases:9.67%
controls:6.48%
15
175
583
5767
21
104
577
5838
48
16
550
5926
—
45
14
552
5928
74
87
517
5827
52
357
486
5155
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-2.0e-01
-1.4e-01
2.4e+00
2.8e+00
2.4e+00
1.3e+00
4.5e-01
cases:24.58%
controls:28.48%
cases:20.23%
controls:22.55%
cases:33.78%
controls:4.41%
cases:4.35%
controls:0.29%
cases:32.83%
controls:4.29%
cases:50.76%
controls:22.47%
cases:58.36%
controls:47.17%
147
1692
451
4250
121
1340
477
4602
202
262
396
5680
26
17
572
5925
196
255
401
5687
300
1329
291
4585
314
2600
224
2912
MCH [Entitic mass]
28539-5 [3035941]
-2.0e-01
-1.4e-01
2.4e+00
2.8e+00
2.4e+00
1.3e+00
4.5e-01
cases:24.58%
controls:28.44%
cases:20.23%
controls:22.52%
cases:33.78%
controls:4.41%
cases:4.35%
controls:0.29%
cases:32.83%
controls:4.29%
cases:50.76%
controls:22.47%
cases:58.36%
controls:47.21%
147
1690
451
4252
121
1338
477
4604
202
262
396
5680
26
17
572
5925
196
255
401
5687
300
1329
291
4585
314
2602
224
2910
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-1.9e-01
-1.4e-01
2.4e+00
2.8e+00
2.4e+00
1.3e+00
4.5e-01
cases:24.92%
controls:28.58%
cases:20.23%
controls:22.60%
cases:33.95%
controls:4.43%
cases:4.35%
controls:0.29%
cases:32.83%
controls:4.29%
cases:50.76%
controls:22.51%
cases:58.36%
controls:47.31%
149
1698
449
4244
121
1343
477
4599
203
263
395
5679
26
17
572
5925
196
255
401
5687
300
1331
291
4583
314
2608
224
2904
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-2.0e-01
-1.4e-01
2.4e+00
2.8e+00
2.4e+00
1.3e+00
4.5e-01
cases:24.58%
controls:28.49%
cases:20.23%
controls:22.55%
cases:33.78%
controls:4.41%
cases:4.35%
controls:0.29%
cases:32.83%
controls:4.29%
cases:50.76%
controls:22.52%
cases:58.36%
controls:47.22%
147
1693
451
4249
121
1340
477
4602
202
262
396
5680
26
17
572
5925
196
255
401
5687
300
1332
291
4582
314
2603
224
2909
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-2.0e-01
-1.4e-01
2.4e+00
2.8e+00
2.4e+00
1.3e+00
4.5e-01
cases:24.58%
controls:28.53%
cases:20.23%
controls:22.55%
cases:33.78%
controls:4.41%
cases:4.35%
controls:0.29%
cases:32.83%
controls:4.29%
cases:50.76%
controls:22.52%
cases:58.36%
controls:47.24%
147
1695
451
4247
121
1340
477
4602
202
262
396
5680
26
17
572
5925
196
255
401
5687
300
1332
291
4582
314
2604
224
2908
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-2.0e-01
-1.3e-01
2.4e+00
2.8e+00
2.4e+00
1.3e+00
4.5e-01
cases:24.75%
controls:28.58%
cases:20.40%
controls:22.64%
cases:33.78%
controls:4.43%
cases:4.35%
controls:0.29%
cases:32.83%
controls:4.33%
cases:50.76%
controls:22.54%
cases:58.36%
controls:47.26%
148
1698
450
4244
122
1345
476
4597
202
263
396
5679
26
17
572
5925
196
257
401
5685
300
1333
291
4581
314
2605
224
2907
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
-2.7e-01
7.9e-01
3.1e+00
—
3.1e+00
2.2e+00
7.8e-01
cases:1.67%
controls:2.19%
cases:2.34%
controls:1.08%
cases:4.01%
controls:0.19%
—
—
cases:3.18%
controls:0.15%
cases:6.60%
controls:0.74%
cases:5.58%
controls:2.63%
10
130
588
5812
14
64
584
5878
24
11
574
5931
—
19
9
578
5933
39
44
552
5870
30
145
508
5367
Osmolality of Urine
2695-5 [3026782]
-2.3e-01
5.9e-01
3.2e+00
—
3.1e+00
2.1e+00
8.3e-01
cases:1.84%
controls:2.31%
cases:2.01%
controls:1.13%
cases:3.85%
controls:0.17%
—
—
cases:3.35%
controls:0.15%
cases:6.77%
controls:0.90%
cases:5.58%
controls:2.50%
11
137
587
5805
12
67
586
5875
23
10
575
5932
—
20
9
577
5933
40
53
551
5861
30
138
508
5374
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-2.8e-01
-8.4e-02
2.7e+00
2.9e+00
2.6e+00
1.1e+00
2.5e-01
cases:16.22%
controls:20.40%
cases:14.38%
controls:15.45%
cases:27.93%
controls:2.66%
cases:3.68%
controls:0.22%
cases:27.14%
controls:2.64%
cases:35.36%
controls:15.67%
cases:40.33%
controls:34.52%
97
1212
501
4730
86
918
512
5024
167
158
431
5784
22
13
576
5929
162
157
435
5785
209
927
382
4987
217
1903
321
3609
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
-1.5e-01
6.2e-01
3.4e+00
—
2.7e+00
2.2e+00
9.3e-01
cases:2.34%
controls:2.71%
cases:2.34%
controls:1.28%
cases:3.85%
controls:0.13%
—
—
cases:1.68%
controls:0.12%
cases:8.63%
controls:1.03%
cases:8.18%
controls:3.41%
14
161
584
5781
14
76
584
5866
23
8
575
5934
—
10
7
587
5935
51
61
540
5853
44
188
494
5324
Inpatient Hospital
21 [8717]
-1.6e-01
6.2e-02
3.2e+00
—
3.4e+00
2.1e+00
4.8e-01
cases:18.06%
controls:20.58%
cases:7.53%
controls:7.10%
cases:21.24%
controls:1.13%
—
—
cases:27.64%
controls:1.21%
cases:33.84%
controls:6.12%
cases:21.19%
controls:14.31%
108
1223
490
4719
45
422
553
5520
127
67
471
5875
—
165
72
432
5870
200
362
391
5552
114
789
424
4723
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-1.0e-01
1.9e-01
2.1e+00
2.6e+00
2.7e+00
1.4e+00
3.2e-01
cases:19.57%
controls:21.20%
cases:15.72%
controls:13.41%
cases:15.22%
controls:2.20%
cases:2.51%
controls:0.19%
cases:25.13%
controls:2.12%
cases:37.23%
controls:13.16%
cases:40.52%
controls:33.11%
117
1260
481
4682
94
797
504
5145
91
131
507
5811
15
11
583
5931
150
126
447
5816
220
778
371
5136
218
1825
320
3687
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.0e-01
8.0e-01
3.2e+00
—
3.0e+00
2.1e+00
3.5e-01
cases:7.19%
controls:6.55%
cases:7.53%
controls:3.52%
cases:12.54%
controls:0.56%
—
—
cases:8.54%
controls:0.45%
cases:19.97%
controls:3.09%
cases:14.31%
controls:10.49%
43
389
555
5553
45
209
553
5733
75
33
523
5909
—
51
27
546
5915
118
183
473
5731
77
578
461
4934
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
-1.1e-01
5.2e-01
3.4e+00
—
3.5e+00
2.2e+00
5.1e-01
cases:3.18%
controls:3.53%
cases:3.68%
controls:2.22%
cases:8.36%
controls:0.30%
—
—
cases:7.54%
controls:0.25%
cases:12.86%
controls:1.62%
cases:9.48%
controls:5.93%
19
210
579
5732
22
132
576
5810
50
18
548
5924
—
45
15
552
5927
76
96
515
5818
51
327
487
5185
Follitropin [Units/volume] in Serum or Plasma
15067-2 [3023323]
—
—
—
—
1.0e+50
4.6e+00
4.4e+00
—
—
—
—
—
—
—
—
cases:9.21%
controls:0.00%
cases:13.71%
controls:0.15%
cases:19.52%
controls:0.31%
—
—
—
—
55
0
542
5942
81
9
510
5905
105
17
433
5495
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
-1.9e-01
-2.6e-01
2.0e+00
—
3.4e+00
2.3e+00
1.3e+00
cases:9.87%
controls:11.66%
cases:6.19%
controls:7.89%
cases:8.36%
controls:1.18%
—
—
cases:25.96%
controls:1.14%
cases:42.64%
controls:7.20%
cases:44.80%
controls:18.25%
59
693
539
5249
37
469
561
5473
50
70
548
5872
—
155
68
442
5874
252
426
339
5488
241
1006
297
4506
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
7.9e-02
2.9e-01
1.7e+00
4.1e+00
3.1e+00
3.5e-01
1.7e-01
cases:31.10%
controls:29.43%
cases:15.89%
controls:12.34%
cases:9.20%
controls:1.80%
cases:5.85%
controls:0.10%
cases:27.81%
controls:1.68%
cases:16.58%
controls:12.31%
cases:36.80%
controls:32.86%
186
1749
412
4193
95
733
503
5209
55
107
543
5835
35
6
563
5936
166
100
431
5842
98
728
493
5186
198
1811
340
3701
ibuprofen
R02AX02 [1588667]
7.9e-02
2.9e-01
1.7e+00
4.1e+00
3.1e+00
3.5e-01
1.7e-01
cases:31.10%
controls:29.43%
cases:15.89%
controls:12.34%
cases:9.20%
controls:1.80%
cases:5.85%
controls:0.10%
cases:27.81%
controls:1.68%
cases:16.58%
controls:12.31%
cases:36.80%
controls:32.86%
186
1749
412
4193
95
733
503
5209
55
107
543
5835
35
6
563
5936
166
100
431
5842
98
728
493
5186
198
1811
340
3701
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
-6.6e-02
-1.8e-02
2.3e+00
—
4.4e+00
2.0e+00
4.1e-01
cases:2.51%
controls:2.68%
cases:1.51%
controls:1.53%
cases:1.34%
controls:0.13%
—
—
cases:12.40%
controls:0.17%
cases:8.63%
controls:1.30%
cases:6.69%
controls:4.55%
15
159
583
5783
9
91
589
5851
8
8
590
5934
—
74
10
523
5932
51
77
540
5837
36
251
502
5261
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
-5.6e-02
1.8e-01
3.9e+00
—
3.0e+00
1.6e+00
2.9e-01
cases:4.52%
controls:4.76%
cases:2.84%
controls:2.39%
cases:12.21%
controls:0.27%
—
—
cases:7.20%
controls:0.37%
cases:8.63%
controls:1.89%
cases:8.18%
controls:6.24%
27
283
571
5659
17
142
581
5800
73
16
525
5926
—
43
22
554
5920
51
112
540
5802
44
344
494
5168
Body CT examination
JN4AD [2001310897]
-1.0e+50
—
1.0e+50
1.0e+50
1.0e+50
4.8e+00
3.5e+00
cases:0.00%
controls:0.19%
—
—
cases:2.17%
controls:0.00%
cases:0.84%
controls:0.00%
cases:3.02%
controls:0.00%
cases:11.17%
controls:0.10%
cases:16.17%
controls:0.58%
0
11
598
5931
—
13
0
585
5942
5
0
593
5942
18
0
579
5942
66
6
525
5908
87
32
451
5480
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-1.3e-01
3.8e-02
2.6e+00
—
3.5e+00
1.6e+00
4.4e-01
cases:6.02%
controls:6.78%
cases:4.35%
controls:4.19%
cases:7.02%
controls:0.54%
—
—
cases:17.09%
controls:0.62%
cases:16.75%
controls:3.79%
cases:15.80%
controls:10.79%
36
403
562
5539
26
249
572
5693
42
32
556
5910
—
102
37
495
5905
99
224
492
5690
85
595
453
4917
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-2.4e-01
-1.7e-01
2.3e+00
2.6e+00
2.2e+00
9.0e-01
1.7e-01
cases:17.89%
controls:21.74%
cases:13.88%
controls:16.00%
cases:23.58%
controls:3.00%
cases:3.68%
controls:0.27%
cases:22.45%
controls:3.23%
cases:31.81%
controls:15.89%
cases:39.22%
controls:35.36%
107
1292
491
4650
83
951
515
4991
141
178
457
5764
22
16
576
5926
134
192
463
5750
188
940
403
4974
211
1949
327
3563
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
-2.2e-01
5.4e-02
2.0e+00
—
3.2e+00
2.1e+00
5.2e-01
cases:3.85%
controls:4.73%
cases:3.51%
controls:3.33%
cases:5.18%
controls:0.72%
—
—
cases:12.40%
controls:0.56%
cases:19.80%
controls:3.06%
cases:13.20%
controls:8.33%
23
281
575
5661
21
198
577
5744
31
43
567
5899
—
74
33
523
5909
117
181
474
5733
71
459
467
5053
Thorax X-ray examination
GD1AA [2001303617]
2.2e-01
5.0e-01
9.1e-01
—
2.3e+00
3.2e+00
2.3e+00
cases:6.35%
controls:5.15%
cases:3.01%
controls:1.85%
cases:0.84%
controls:0.34%
—
—
cases:2.35%
controls:0.24%
cases:28.09%
controls:1.64%
cases:34.94%
controls:5.03%
38
306
560
5636
18
110
580
5832
5
20
593
5922
—
14
14
583
5928
166
97
425
5817
188
277
350
5235
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
—
—
—
—
1.0e+50
4.2e+00
3.5e+00
—
—
—
—
—
—
—
—
cases:9.55%
controls:0.00%
cases:15.06%
controls:0.27%
cases:22.49%
controls:0.85%
—
—
—
—
57
0
540
5942
89
16
502
5898
121
47
417
5465
Normoblasts [#/volume] in Blood
715-3 [3021589]
-9.0e-02
-2.1e-01
2.2e+00
—
3.1e+00
1.6e+00
7.3e-01
cases:4.85%
controls:5.28%
cases:4.18%
controls:5.12%
cases:8.19%
controls:0.96%
—
—
cases:15.58%
controls:0.86%
cases:19.29%
controls:4.80%
cases:21.56%
controls:11.74%
29
314
569
5628
25
304
573
5638
49
57
549
5885
—
93
51
504
5891
114
284
477
5630
116
647
422
4865
Extensive abdominal CT
JN3BD [2001305556]
1.2e-01
—
—
—
—
4.0e+00
3.5e+00
cases:1.00%
controls:0.89%
—
—
—
—
—
—
—
—
cases:7.95%
controls:0.15%
cases:10.41%
controls:0.36%
6
53
592
5889
—
—
—
—
47
9
544
5905
56
20
482
5492
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.4e-01
6.4e-01
9.1e-01
—
4.0e+00
2.4e+00
9.7e-01
cases:1.34%
controls:1.16%
cases:1.84%
controls:0.98%
cases:0.84%
controls:0.34%
—
—
cases:10.72%
controls:0.22%
cases:11.68%
controls:1.15%
cases:6.32%
controls:2.50%
8
69
590
5873
11
58
587
5884
5
20
593
5922
—
64
13
533
5929
69
68
522
5846
34
138
504
5374
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
-3.7e-01
2.4e-01
—
—
4.7e+00
2.0e+00
6.9e-01
cases:1.17%
controls:1.68%
cases:1.00%
controls:0.79%
—
—
—
—
cases:8.21%
controls:0.08%
cases:5.08%
controls:0.69%
cases:6.13%
controls:3.17%
7
100
591
5842
6
47
592
5895
—
—
49
5
548
5937
30
41
561
5873
33
175
505
5337
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-1.3e-01
-1.2e-01
1.1e+00
—
3.1e+00
2.1e+00
1.0e+00
cases:7.36%
controls:8.33%
cases:5.35%
controls:5.97%
cases:4.35%
controls:1.55%
—
—
cases:22.61%
controls:1.33%
cases:31.47%
controls:5.48%
cases:28.25%
controls:12.52%
44
495
554
5447
32
355
566
5587
26
92
572
5850
—
135
79
462
5863
186
324
405
5590
152
690
386
4822
Scheduled procedure
ZXD10 [2001311387]
-4.4e-02
3.1e-01
3.9e+00
1.0e+50
—
2.1e+00
1.2e+00
cases:3.18%
controls:3.32%
cases:1.51%
controls:1.11%
cases:5.35%
controls:0.12%
cases:7.69%
controls:0.00%
—
—
cases:5.58%
controls:0.71%
cases:5.02%
controls:1.52%
19
197
579
5745
9
66
589
5876
32
7
566
5935
46
0
552
5942
—
33
42
558
5872
27
84
511
5428
Intravenous
ZX120 [2001311495]
—
—
—
—
2.9e+00
2.7e+00
1.4e+00
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.08%
cases:4.74%
controls:0.32%
cases:2.04%
controls:0.49%
—
—
—
—
9
5
588
5937
28
19
563
5895
11
27
527
5485
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
—
—
2.6e+00
—
2.3e+00
2.2e+00
7.9e-01
—
—
—
—
cases:1.51%
controls:0.12%
—
—
cases:1.17%
controls:0.12%
cases:5.08%
controls:0.59%
cases:4.09%
controls:1.90%
—
—
9
7
589
5935
—
7
7
590
5935
30
35
561
5879
22
105
516
5407
Emergency Room and Inpatient Visit
ERIP [262]
-1.6e-01
3.8e-01
2.8e+00
—
2.5e+00
1.7e+00
2.1e-01
cases:1.34%
controls:1.57%
cases:1.84%
controls:1.26%
cases:2.17%
controls:0.13%
—
—
cases:2.01%
controls:0.17%
cases:7.61%
controls:1.56%
cases:7.43%
controls:6.13%
8
93
590
5849
11
75
587
5867
13
8
585
5934
—
12
10
585
5932
45
92
546
5822
40
338
498
5174
Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]
—
—
1.0e+50
1.0e+50
1.0e+50
—
6.9e+00
—
—
—
—
cases:24.41%
controls:0.00%
cases:1.84%
controls:0.00%
cases:24.79%
controls:0.00%
—
—
cases:47.96%
controls:0.09%
—
—
146
0
452
5942
11
0
587
5942
148
0
449
5942
—
258
5
280
5507
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
5.8e-01
9.7e-01
—
—
—
5.1e+00
1.7e+00
cases:1.67%
controls:0.94%
cases:0.84%
controls:0.32%
—
—
—
—
—
—
cases:32.32%
controls:0.29%
cases:7.06%
controls:1.31%
10
56
588
5886
5
19
593
5923
—
—
—
191
17
400
5897
38
72
500
5440
General anesthesia, balanced
WX408 [2001310808]
2.1e-01
2.4e-01
3.2e+00
1.0e+50
—
2.4e+00
1.3e+00
cases:3.34%
controls:2.73%
cases:1.00%
controls:0.79%
cases:2.01%
controls:0.08%
cases:5.69%
controls:0.00%
—
—
cases:5.25%
controls:0.51%
cases:3.90%
controls:1.12%
20
162
578
5780
6
47
592
5895
12
5
586
5937
34
0
564
5942
—
31
30
560
5884
21
62
517
5450
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
1.9e-02
1.7e+00
3.8e+00
—
1.7e+00
1.2e+00
3.2e-01
cases:4.18%
controls:4.11%
cases:5.85%
controls:1.09%
cases:3.51%
controls:0.08%
—
—
cases:0.84%
controls:0.15%
cases:3.05%
controls:0.90%
cases:5.02%
controls:3.68%
25
244
573
5698
35
65
563
5877
21
5
577
5937
—
5
9
592
5933
18
53
573
5861
27
203
511
5309
oxycodone; oral, parenteral
N02AA05 [21604260]
5.1e-01
—
—
—
2.8e+00
2.8e+00
1.2e+00
cases:1.00%
controls:0.61%
—
—
—
—
—
—
cases:1.84%
controls:0.12%
cases:6.26%
controls:0.41%
cases:2.42%
controls:0.76%
6
36
592
5906
—
—
—
11
7
586
5935
37
24
554
5890
13
42
525
5470
Tissue Pathology biopsy report
66121-5 [40768804]
-2.1e-01
2.5e-01
1.7e+00
1.0e+50
3.8e+00
2.0e+00
6.6e-01
cases:2.68%
controls:3.28%
cases:2.01%
controls:1.57%
cases:0.84%
controls:0.15%
cases:16.56%
controls:0.00%
cases:4.36%
controls:0.10%
cases:6.94%
controls:1.00%
cases:8.18%
controls:4.41%
16
195
582
5747
12
93
586
5849
5
9
593
5933
99
0
499
5942
26
6
571
5936
41
59
550
5855
44
243
494
5269
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
6.9e-01
8.6e-01
3.8e+00
—
—
2.5e+00
2.9e-01
cases:1.51%
controls:0.76%
cases:1.51%
controls:0.64%
cases:4.35%
controls:0.10%
—
—
—
—
cases:7.45%
controls:0.68%
cases:3.72%
controls:2.81%
9
45
589
5897
9
38
589
5904
26
6
572
5936
—
—
44
40
547
5874
20
155
518
5357
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
6.6e-01
9.8e-01
3.8e+00
—
—
2.5e+00
2.8e-01
cases:1.17%
controls:0.61%
cases:1.51%
controls:0.57%
cases:4.18%
controls:0.10%
—
—
—
—
cases:7.45%
controls:0.66%
cases:3.90%
controls:2.98%
7
36
591
5906
9
34
589
5908
25
6
573
5936
—
—
44
39
547
5875
21
164
517
5348
More than one and less than three hours
ZXE10 [2001311401]
-5.4e-02
3.7e-01
3.8e+00
1.0e+50
1.0e+50
1.6e+00
9.0e-01
cases:3.18%
controls:3.35%
cases:1.51%
controls:1.04%
cases:4.18%
controls:0.10%
cases:8.86%
controls:0.00%
cases:3.18%
controls:0.00%
cases:2.71%
controls:0.57%
cases:4.28%
controls:1.78%
19
199
579
5743
9
62
589
5880
25
6
573
5936
53
0
545
5942
19
0
578
5942
16
34
575
5880
23
98
515
5414
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.0e-01
4.7e-01
1.6e+00
1.0e+50
2.5e+00
1.4e+00
6.9e-01
cases:5.35%
controls:4.86%
cases:2.51%
controls:1.58%
cases:1.67%
controls:0.34%
cases:1.51%
controls:0.00%
cases:4.86%
controls:0.40%
cases:6.43%
controls:1.67%
cases:9.67%
controls:5.10%
32
289
566
5653
15
94
583
5848
10
20
588
5922
9
0
589
5942
29
24
568
5918
38
99
553
5815
52
281
486
5231
Short blood count panel - Blood
55429-5 [40758558]
-6.1e-01
-1.1e-01
1.1e+00
—
3.2e+00
2.0e+00
1.1e+00
cases:2.34%
controls:4.21%
cases:2.17%
controls:2.42%
cases:1.67%
controls:0.59%
—
—
cases:10.39%
controls:0.49%
cases:12.18%
controls:1.88%
cases:10.97%
controls:4.03%
14
250
584
5692
13
144
585
5798
10
35
588
5907
—
62
29
535
5913
72
111
519
5803
59
222
479
5290
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
-1.3e-01
5.0e-01
2.4e+00
—
2.4e+00
1.4e+00
1.5e-01
cases:7.53%
controls:8.45%
cases:6.86%
controls:4.27%
cases:7.86%
controls:0.76%
—
—
cases:5.70%
controls:0.54%
cases:14.89%
controls:4.28%
cases:15.06%
controls:13.24%
45
502
553
5440
41
254
557
5688
47
45
551
5897
—
34
32
563
5910
88
253
503
5661
81
730
457
4782
12 lead EKG panel
34534-8 [3044889]
-2.1e-01
-1.2e-01
2.5e+00
—
2.7e+00
8.1e-01
3.7e-02
cases:8.19%
controls:9.90%
cases:5.02%
controls:5.64%
cases:8.70%
controls:0.77%
—
—
cases:9.88%
controls:0.71%
cases:11.51%
controls:5.44%
cases:17.66%
controls:17.13%
49
588
549
5354
30
335
568
5607
52
46
546
5896
—
59
42
538
5900
68
322
523
5592
95
944
443
4568
Emergency Room Visit
ER [9203]
2.3e-02
3.7e-01
2.6e+00
—
2.2e+00
1.2e+00
2.6e-01
cases:29.10%
controls:28.63%
cases:12.54%
controls:9.00%
cases:12.54%
controls:1.03%
—
—
cases:9.55%
controls:1.18%
cases:22.34%
controls:7.90%
cases:24.54%
controls:20.05%
174
1701
424
4241
75
535
523
5407
75
61
523
5881
—
57
70
540
5872
132
467
459
5447
132
1105
406
4407
Abdominal CT examination
JN3AD [2001305554]
-1.0e+50
—
—
—
—
3.4e+00
2.6e+00
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
cases:6.94%
controls:0.25%
cases:12.64%
controls:1.07%
0
19
598
5923
—
—
—
—
41
15
550
5899
68
59
470
5453
Bacteria identified in Blood by Culture
600-7 [3023368]
2.6e-01
7.5e-01
—
—
3.0e+00
2.3e+00
6.5e-01
cases:3.34%
controls:2.61%
cases:3.01%
controls:1.45%
—
—
—
—
cases:4.52%
controls:0.24%
cases:10.49%
controls:1.17%
cases:7.62%
controls:4.12%
20
155
578
5787
18
86
580
5856
—
—
27
14
570
5928
62
69
529
5845
41
227
497
5285
FEV1
20150-9 [3024653]
—
7.3e-01
—
—
—
4.0e+00
1.9e+00
—
—
cases:0.84%
controls:0.40%
—
—
—
—
—
—
cases:8.46%
controls:0.17%
cases:3.16%
controls:0.51%
—
5
24
593
5918
—
—
—
50
10
541
5904
17
28
521
5484
FEV1/FVC
19926-5 [3011505]
—
7.3e-01
—
—
—
4.0e+00
1.9e+00
—
—
cases:0.84%
controls:0.40%
—
—
—
—
—
—
cases:8.46%
controls:0.17%
cases:3.16%
controls:0.51%
—
5
24
593
5918
—
—
—
50
10
541
5904
17
28
521
5484
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
—
7.3e-01
—
—
—
4.0e+00
1.9e+00
—
—
cases:0.84%
controls:0.40%
—
—
—
—
—
—
cases:8.46%
controls:0.17%
cases:3.16%
controls:0.51%
—
5
24
593
5918
—
—
—
50
10
541
5904
17
28
521
5484
Office Visit
OMOP4822458 [581477]
-1.5e-01
-1.6e-02
—
—
2.8e+00
2.2e+00
8.7e-01
cases:5.52%
controls:6.36%
cases:1.84%
controls:1.87%
—
—
—
—
cases:3.18%
controls:0.20%
cases:10.66%
controls:1.37%
cases:8.74%
controls:3.85%
33
378
565
5564
11
111
587
5831
—
—
19
12
578
5930
63
81
528
5833
47
212
491
5300
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-4.8e-01
—
2.7e+00
—
—
2.2e+00
8.9e-01
cases:0.84%
controls:1.35%
—
—
cases:1.51%
controls:0.10%
—
—
—
—
cases:5.25%
controls:0.63%
cases:4.46%
controls:1.89%
5
80
593
5862
—
9
6
589
5936
—
—
31
37
560
5877
24
104
514
5408
Monocytes [#/volume] in Blood
26484-6 [3001604]
-1.1e-01
-3.3e-01
9.8e-01
—
2.9e+00
1.4e+00
4.5e-01
cases:6.35%
controls:7.05%
cases:3.85%
controls:5.27%
cases:3.18%
controls:1.21%
—
—
cases:14.41%
controls:0.89%
cases:16.58%
controls:4.67%
cases:17.10%
controls:11.61%
38
419
560
5523
23
313
575
5629
19
72
579
5870
—
86
53
511
5889
98
276
493
5638
92
640
446
4872
Basophils [#/volume] in Blood
26444-0 [3006315]
-7.9e-02
-3.3e-01
9.8e-01
—
2.9e+00
1.4e+00
4.3e-01
cases:6.52%
controls:7.02%
cases:3.85%
controls:5.27%
cases:3.18%
controls:1.21%
—
—
cases:14.41%
controls:0.89%
cases:16.41%
controls:4.67%
cases:16.91%
controls:11.67%
39
417
559
5525
23
313
575
5629
19
72
579
5870
—
86
53
511
5889
97
276
494
5638
91
643
447
4869
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-6.0e-02
-3.2e-01
9.8e-01
—
2.9e+00
1.4e+00
4.5e-01
cases:7.36%
controls:7.78%
cases:4.01%
controls:5.47%
cases:3.18%
controls:1.21%
—
—
cases:14.57%
controls:0.93%
cases:17.09%
controls:4.89%
cases:17.66%
controls:12.03%
44
462
554
5480
24
325
574
5617
19
72
579
5870
—
87
55
510
5887
101
289
490
5625
95
663
443
4849
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-5.0e-02
-3.8e-01
9.7e-01
—
2.8e+00
1.4e+00
4.5e-01
cases:7.02%
controls:7.35%
cases:3.85%
controls:5.52%
cases:3.34%
controls:1.30%
—
—
cases:14.57%
controls:1.03%
cases:17.26%
controls:4.94%
cases:17.66%
controls:12.03%
42
437
556
5505
23
328
575
5614
20
77
578
5865
—
87
61
510
5881
102
292
489
5622
95
663
443
4849
Case Management Agency
251B00000X [38004193]
-2.1e-01
-1.6e-01
1.3e+00
2.5e+00
1.3e+00
5.1e-01
1.8e-01
cases:51.51%
controls:56.70%
cases:41.97%
controls:45.84%
cases:39.63%
controls:15.21%
cases:10.54%
controls:0.99%
cases:41.88%
controls:15.99%
cases:61.08%
controls:48.41%
cases:71.00%
controls:67.13%
308
3369
290
2573
251
2724
347
3218
237
904
361
5038
63
59
535
5883
250
950
347
4992
361
2863
230
3051
382
3700
156
1812
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
-1.6e-01
5.9e-01
2.5e+00
—
2.1e+00
9.2e-01
1.9e-01
cases:2.68%
controls:3.11%
cases:2.68%
controls:1.50%
cases:3.18%
controls:0.27%
—
—
cases:1.34%
controls:0.17%
cases:3.89%
controls:1.59%
cases:7.25%
controls:6.10%
16
185
582
5757
16
89
582
5853
19
16
579
5926
—
8
10
589
5932
23
94
568
5820
39
336
499
5176
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.0e-03
-2.7e-01
9.6e-01
—
2.9e+00
1.5e+00
3.8e-01
cases:6.52%
controls:6.48%
cases:3.85%
controls:4.96%
cases:3.01%
controls:1.18%
—
—
cases:14.07%
controls:0.86%
cases:17.26%
controls:4.29%
cases:14.87%
controls:10.67%
39
385
559
5557
23
295
575
5647
18
70
580
5872
—
84
51
513
5891
102
254
489
5660
80
588
458
4924
Basophils/Leukocytes in Blood
30180-4 [3022096]
7.0e-03
-3.1e-01
9.6e-01
—
2.9e+00
1.5e+00
3.9e-01
cases:6.52%
controls:6.48%
cases:3.68%
controls:4.95%
cases:3.01%
controls:1.18%
—
—
cases:14.07%
controls:0.86%
cases:17.26%
controls:4.31%
cases:15.06%
controls:10.67%
39
385
559
5557
22
294
576
5648
18
70
580
5872
—
84
51
513
5891
102
255
489
5659
81
588
457
4924
Monocytes/Leukocytes in Blood
26485-3 [3019069]
2.6e-02
-2.3e-01
9.6e-01
—
2.9e+00
1.5e+00
3.9e-01
cases:6.69%
controls:6.53%
cases:4.01%
controls:5.02%
cases:3.01%
controls:1.18%
—
—
cases:14.07%
controls:0.86%
cases:17.43%
controls:4.36%
cases:15.06%
controls:10.74%
40
388
558
5554
24
298
574
5644
18
70
580
5872
—
84
51
513
5891
103
258
488
5656
81
592
457
4920
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.1e-01
-7.1e-01
6.6e-01
—
3.2e+00
1.6e+00
5.8e-01
cases:5.02%
controls:3.74%
cases:1.84%
controls:3.69%
cases:1.67%
controls:0.88%
—
—
cases:12.06%
controls:0.56%
cases:13.87%
controls:3.03%
cases:11.71%
controls:6.89%
30
222
568
5720
11
219
587
5723
10
52
588
5890
—
72
33
525
5909
82
179
509
5735
63
380
475
5132
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-2.9e-01
-2.2e-01
1.1e+00
—
2.6e+00
1.3e+00
4.0e-01
cases:18.06%
controls:22.74%
cases:14.21%
controls:17.13%
cases:8.70%
controls:2.98%
—
—
cases:26.30%
controls:2.66%
cases:43.65%
controls:17.86%
cases:50.74%
controls:40.80%
108
1351
490
4591
85
1018
513
4924
52
177
546
5765
—
157
158
440
5784
258
1056
333
4858
273
2249
265
3263
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-3.7e-02
-2.3e-01
9.4e-01
—
2.9e+00
1.5e+00
4.1e-01
cases:7.02%
controls:7.27%
cases:4.18%
controls:5.20%
cases:3.01%
controls:1.19%
—
—
cases:14.24%
controls:0.88%
cases:17.60%
controls:4.57%
cases:15.99%
controls:11.25%
42
432
556
5510
25
309
573
5633
18
71
580
5871
—
85
52
512
5890
104
270
487
5644
86
620
452
4892
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
-1.7e-01
-2.1e-01
—
—
—
3.0e+00
2.3e+00
cases:1.34%
controls:1.58%
cases:0.84%
controls:1.03%
—
—
—
—
—
—
cases:18.78%
controls:1.13%
cases:31.60%
controls:4.44%
8
94
590
5848
5
61
593
5881
—
—
—
111
67
480
5847
170
245
368
5267
FEV1 --post bronchodilation
20155-8 [3023550]
—
9.1e-01
—
—
—
3.6e+00
1.7e+00
—
—
cases:0.84%
controls:0.34%
—
—
—
—
—
—
cases:4.74%
controls:0.14%
cases:2.42%
controls:0.45%
—
5
20
593
5922
—
—
—
28
8
563
5906
13
25
525
5487
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
—
9.1e-01
—
—
—
3.6e+00
1.7e+00
—
—
cases:0.84%
controls:0.34%
—
—
—
—
—
—
cases:4.74%
controls:0.14%
cases:2.42%
controls:0.45%
—
5
20
593
5922
—
—
—
28
8
563
5906
13
25
525
5487
FEV1/FVC --post bronchodilation
69970-2 [42868459]
—
9.1e-01
—
—
—
3.6e+00
1.7e+00
—
—
cases:0.84%
controls:0.34%
—
—
—
—
—
—
cases:4.74%
controls:0.14%
cases:2.42%
controls:0.45%
—
5
20
593
5922
—
—
—
28
8
563
5906
13
25
525
5487
FEV1 percent change
69983-5 [42868472]
—
9.1e-01
—
—
—
3.6e+00
1.7e+00
—
—
cases:0.84%
controls:0.34%
—
—
—
—
—
—
cases:4.74%
controls:0.14%
cases:2.42%
controls:0.45%
—
5
20
593
5922
—
—
—
28
8
563
5906
13
25
525
5487
FVC percent change Respiratory system
69982-7 [42868471]
—
9.1e-01
—
—
—
3.6e+00
1.7e+00
—
—
cases:0.84%
controls:0.34%
—
—
—
—
—
—
cases:4.74%
controls:0.14%
cases:2.42%
controls:0.45%
—
5
20
593
5922
—
—
—
28
8
563
5906
13
25
525
5487
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
7.2e-02
-1.8e-01
9.3e-01
—
2.8e+00
1.5e+00
3.7e-01
cases:7.36%
controls:6.88%
cases:4.18%
controls:4.98%
cases:2.84%
controls:1.14%
—
—
cases:12.73%
controls:0.84%
cases:16.58%
controls:4.43%
cases:15.24%
controls:11.05%
44
409
554
5533
25
296
573
5646
17
68
581
5874
—
76
50
521
5892
98
262
493
5652
82
609
456
4903
EKG study
11524-6 [3013512]
-4.2e-02
1.4e-01
2.1e+00
—
1.9e+00
1.2e+00
-4.4e-02
cases:2.84%
controls:2.96%
cases:2.17%
controls:1.90%
cases:1.51%
controls:0.19%
—
—
cases:1.34%
controls:0.20%
cases:5.92%
controls:1.86%
cases:5.76%
controls:6.01%
17
176
581
5766
13
113
585
5829
9
11
589
5931
—
8
12
589
5930
35
110
556
5804
31
331
507
5181
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.3e-01
-4.5e-01
9.5e-01
—
2.7e+00
2.0e+00
5.0e-01
cases:4.52%
controls:3.99%
cases:1.84%
controls:2.84%
cases:1.34%
controls:0.52%
—
—
cases:7.20%
controls:0.54%
cases:16.75%
controls:2.54%
cases:10.78%
controls:6.82%
27
237
571
5705
11
169
587
5773
8
31
590
5911
—
43
32
554
5910
99
150
492
5764
58
376
480
5136
Extensive body CT
JN4BD [2001310899]
5.8e-01
1.5e+00
1.0e+50
1.0e+50
1.0e+50
—
5.2e+00
cases:0.84%
controls:0.47%
cases:0.84%
controls:0.19%
cases:4.52%
controls:0.00%
cases:3.68%
controls:0.00%
cases:8.21%
controls:0.00%
—
—
cases:20.63%
controls:0.15%
5
28
593
5914
5
11
593
5931
27
0
571
5942
22
0
576
5942
49
0
548
5942
—
111
8
427
5504
Audiology
64 [38004489]
—
—
—
—
2.8e+00
2.4e+00
8.6e-01
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.10%
cases:7.95%
controls:0.81%
cases:3.16%
controls:1.36%
—
—
—
—
10
6
587
5936
47
48
544
5866
17
75
521
5437
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.5e-02
6.0e-01
2.5e+00
—
1.6e+00
1.1e+00
-3.9e-02
cases:4.85%
controls:4.64%
cases:4.68%
controls:2.63%
cases:5.02%
controls:0.44%
—
—
cases:2.01%
controls:0.42%
cases:7.61%
controls:2.79%
cases:10.41%
controls:10.78%
29
276
569
5666
28
156
570
5786
30
26
568
5916
—
12
25
585
5917
45
165
546
5749
56
594
482
4918
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
7.7e-02
5.9e-01
2.4e+00
—
1.6e+00
1.1e+00
-4.1e-02
cases:5.02%
controls:4.66%
cases:4.68%
controls:2.64%
cases:5.02%
controls:0.45%
—
—
cases:2.01%
controls:0.42%
cases:7.61%
controls:2.79%
cases:10.59%
controls:10.99%
30
277
568
5665
28
157
570
5785
30
27
568
5915
—
12
25
585
5917
45
165
546
5749
57
606
481
4906
cefalexin; oral
J01DB01 [21602870]
1.2e-01
4.7e-01
1.3e+00
—
2.7e+00
1.0e+00
2.9e-01
cases:24.41%
controls:22.23%
cases:9.87%
controls:6.40%
cases:3.01%
controls:0.84%
—
—
cases:10.05%
controls:0.74%
cases:16.24%
controls:6.44%
cases:27.32%
controls:21.90%
146
1321
452
4621
59
380
539
5562
18
50
580
5892
—
60
44
537
5898
96
381
495
5533
147
1207
391
4305
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
6.6e-02
5.9e-01
2.4e+00
—
1.6e+00
1.0e+00
-2.2e-02
cases:5.02%
controls:4.71%
cases:4.68%
controls:2.64%
cases:5.02%
controls:0.45%
—
—
cases:2.01%
controls:0.42%
cases:7.28%
controls:2.79%
cases:10.78%
controls:10.99%
30
280
568
5662
28
157
570
5785
30
27
568
5915
—
12
25
585
5917
43
165
548
5749
58
606
480
4906
pH of Serum or Plasma
2753-2 [3018418]
1.6e-01
-1.7e-01
1.2e+00
—
3.0e+00
2.1e+00
4.1e-01
cases:3.18%
controls:2.71%
cases:1.51%
controls:1.78%
cases:1.17%
controls:0.35%
—
—
cases:5.86%
controls:0.32%
cases:11.00%
controls:1.54%
cases:6.51%
controls:4.41%
19
161
579
5781
9
106
589
5836
7
21
591
5921
—
35
19
562
5923
65
91
526
5823
35
243
503
5269
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
1.5e+00
—
—
—
—
2.8e+00
2.2e+00
cases:0.84%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.08%
cases:1.12%
controls:0.13%
5
11
593
5931
—
—
—
—
8
5
583
5909
6
7
532
5505
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
—
-1.0e+50
—
—
—
2.9e+00
2.1e+00
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:1.52%
controls:0.08%
cases:1.67%
controls:0.22%
—
0
6
598
5936
—
—
—
9
5
582
5909
9
12
529
5500
Supplier / Service Provider
OMOP5117446 [33004]
-1.8e+00
-2.0e+00
8.0e-01
—
—
5.2e+00
3.6e+00
cases:6.35%
controls:29.70%
cases:1.84%
controls:12.35%
cases:2.84%
controls:1.30%
—
—
—
—
cases:23.18%
controls:0.17%
cases:15.99%
controls:0.51%
38
1765
560
4177
11
734
587
5208
17
77
581
5865
—
—
137
10
454
5904
86
28
452
5484
Abdominal ultrasound examination
JN3AE [2001305555]
5.4e-01
—
—
—
—
2.8e+00
2.1e+00
cases:2.17%
controls:1.28%
—
—
—
—
—
—
—
—
cases:3.72%
controls:0.24%
cases:6.69%
controls:0.85%
13
76
585
5866
—
—
—
—
22
14
569
5900
36
47
502
5465
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
5.2e-02
1.8e-01
1.5e+00
—
—
3.6e+00
1.3e+00
cases:1.51%
controls:1.43%
cases:1.00%
controls:0.84%
cases:0.84%
controls:0.19%
—
—
—
—
cases:21.49%
controls:0.78%
cases:7.81%
controls:2.36%
9
85
589
5857
6
50
592
5892
5
11
593
5931
—
—
127
46
464
5868
42
130
496
5382
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
—
—
—
—
—
3.0e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.10%
cases:1.49%
controls:0.25%
—
—
—
—
—
12
6
579
5908
8
14
530
5498
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
—
-1.0e+50
—
—
—
3.2e+00
1.6e+00
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
cases:4.74%
controls:0.20%
cases:2.04%
controls:0.44%
—
0
13
598
5929
—
—
—
28
12
563
5902
11
24
527
5488
Bacteria identified in Isolate by Culture
43409-2 [3042936]
-3.0e-01
—
—
—
3.2e+00
1.6e+00
-3.8e-01
cases:1.00%
controls:1.35%
—
—
—
—
—
—
cases:2.35%
controls:0.10%
cases:3.05%
controls:0.64%
cases:1.49%
controls:2.16%
6
80
592
5862
—
—
—
14
6
583
5936
18
38
573
5876
8
119
530
5393
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.2e-01
-2.2e-01
1.2e+00
—
2.7e+00
2.0e+00
3.5e-01
cases:4.85%
controls:4.31%
cases:2.68%
controls:3.32%
cases:1.84%
controls:0.59%
—
—
cases:8.04%
controls:0.57%
cases:18.10%
controls:2.89%
cases:11.71%
controls:8.56%
29
256
569
5686
16
197
582
5745
11
35
587
5907
—
48
34
549
5908
107
171
484
5743
63
472
475
5040
Emergency Medicine
93 [38004510]
-8.4e-02
-1.0e-01
2.2e+00
—
1.6e+00
8.6e-01
9.6e-02
cases:9.03%
controls:9.74%
cases:5.02%
controls:5.54%
cases:5.69%
controls:0.67%
—
—
cases:4.02%
controls:0.84%
cases:13.54%
controls:6.24%
cases:20.26%
controls:18.76%
54
579
544
5363
30
329
568
5613
34
40
564
5902
—
24
50
573
5892
80
369
511
5545
109
1034
429
4478
INR in Blood by Coagulation assay
34714-6 [3032080]
-1.5e-01
9.8e-02
1.5e+00
1.0e+50
1.3e+00
1.1e+00
6.4e-01
cases:4.18%
controls:4.85%
cases:4.01%
controls:3.65%
cases:4.85%
controls:1.11%
cases:1.67%
controls:0.00%
cases:4.36%
controls:1.19%
cases:10.15%
controls:3.48%
cases:14.31%
controls:8.11%
25
288
573
5654
24
217
574
5725
29
66
569
5876
10
0
588
5942
26
71
571
5871
60
206
531
5708
77
447
461
5065
Pharmacy visit
OMOP4822462 [581458]
-4.8e-02
-8.5e-02
5.2e-01
1.9e+00
1.3e+00
7.9e-01
2.1e-01
cases:79.77%
controls:80.53%
cases:63.04%
controls:65.01%
cases:39.13%
controls:27.68%
cases:9.20%
controls:1.45%
cases:59.13%
controls:28.02%
cases:81.22%
controls:66.23%
cases:89.41%
controls:87.30%
477
4785
121
1157
377
3863
221
2079
234
1645
364
4297
55
86
543
5856
353
1665
244
4277
480
3917
111
1997
481
4812
57
700
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
1.4e+00
—
—
—
-1.0e+50
2.7e+00
1.9e+00
cases:0.84%
controls:0.20%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.12%
cases:1.49%
controls:0.24%
5
12
593
5930
—
—
—
0
5
597
5937
10
7
581
5907
8
13
530
5499
Examination of ears and hearing
Z01.1 [45547279]
-1.0e+50
—
—
—
—
3.3e+00
1.2e+00
cases:0.00%
controls:0.79%
—
—
—
—
—
—
—
—
cases:9.48%
controls:0.37%
cases:3.53%
controls:1.11%
0
47
598
5895
—
—
—
—
56
22
535
5892
19
61
519
5451
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
5.9e-02
2.4e-01
—
—
—
3.3e+00
1.2e+00
cases:1.34%
controls:1.26%
cases:0.84%
controls:0.66%
—
—
—
—
—
—
cases:12.35%
controls:0.51%
cases:6.13%
controls:2.01%
8
75
590
5867
5
39
593
5903
—
—
—
73
30
518
5884
33
111
505
5401
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
—
-1.0e+50
—
—
—
3.2e+00
1.2e+00
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
cases:9.14%
controls:0.39%
cases:2.42%
controls:0.74%
—
0
15
598
5927
—
—
—
54
23
537
5891
13
41
525
5471
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
1.4e+00
—
—
—
-1.0e+50
2.7e+00
1.7e+00
cases:0.84%
controls:0.20%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.12%
cases:1.49%
controls:0.27%
5
12
593
5930
—
—
—
0
5
597
5937
10
7
581
5907
8
15
530
5497
Immunohistochemistry procedure
117617002 [4035726]
—
—
—
1.0e+50
—
2.7e+00
1.7e+00
—
—
—
—
—
—
cases:19.40%
controls:0.00%
—
—
cases:2.20%
controls:0.15%
cases:2.23%
controls:0.42%
—
—
—
116
0
482
5942
—
13
9
578
5905
12
23
526
5489
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
—
—
—
—
—
2.4e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.12%
cases:2.79%
controls:0.42%
—
—
—
—
—
8
7
583
5907
15
23
523
5489
Microorganisms panel - Urine sediment
58435-9 [40761536]
6.6e-01
8.4e-01
2.5e+00
—
—
1.9e+00
5.1e-01
cases:1.84%
controls:0.96%
cases:1.00%
controls:0.44%
cases:1.17%
controls:0.10%
—
—
—
—
cases:2.88%
controls:0.44%
cases:1.86%
controls:1.12%
11
57
587
5885
6
26
592
5916
7
6
591
5936
—
—
17
26
574
5888
10
62
528
5450
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-7.0e-01
-7.6e-01
1.3e+00
—
1.9e+00
9.5e-01
2.4e-01
cases:2.68%
controls:5.25%
cases:1.51%
controls:3.16%
cases:1.84%
controls:0.49%
—
—
cases:2.68%
controls:0.40%
cases:6.94%
controls:2.79%
cases:10.59%
controls:8.49%
16
312
582
5630
9
188
589
5754
11
29
587
5913
—
16
24
581
5918
41
165
550
5749
57
468
481
5044
androstanolone
G03BB02 [21602513]
2.2e-01
4.7e-01
—
—
—
1.6e+00
2.6e+00
cases:0.84%
controls:0.67%
cases:0.84%
controls:0.52%
—
—
—
—
—
—
cases:2.37%
controls:0.49%
cases:8.18%
controls:0.69%
5
40
593
5902
5
31
593
5911
—
—
—
14
29
577
5885
44
38
494
5474
Audiometric test
21727005 [4071702]
-3.5e-01
—
—
—
—
3.0e+00
1.1e+00
cases:0.84%
controls:1.18%
—
—
—
—
—
—
—
—
cases:6.94%
controls:0.37%
cases:2.60%
controls:0.93%
5
70
593
5872
—
—
—
—
41
22
550
5892
14
51
524
5461
androstanolone
A14AA01 [21600917]
2.2e-01
4.7e-01
—
—
—
1.5e+00
2.5e+00
cases:0.84%
controls:0.67%
cases:0.84%
controls:0.52%
—
—
—
—
—
—
cases:2.37%
controls:0.52%
cases:8.55%
controls:0.76%
5
40
593
5902
5
31
593
5911
—
—
—
14
31
577
5883
46
42
492
5470
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-1.1e-01
4.3e-02
1.7e+00
—
1.6e+00
7.1e-01
1.5e-01
cases:9.87%
controls:10.87%
cases:6.19%
controls:5.94%
cases:4.35%
controls:0.82%
—
—
cases:3.35%
controls:0.69%
cases:9.98%
controls:5.16%
cases:18.40%
controls:16.24%
59
646
539
5296
37
353
561
5589
26
49
572
5893
—
20
41
577
5901
59
305
532
5609
99
895
439
4617
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
-3.2e-01
—
1.9e+00
—
2.1e+00
6.6e-01
3.9e-01
cases:1.51%
controls:2.07%
—
—
cases:1.17%
controls:0.17%
—
—
cases:1.17%
controls:0.15%
cases:1.69%
controls:0.88%
cases:2.97%
controls:2.03%
9
123
589
5819
—
7
10
591
5932
—
7
9
590
5933
10
52
581
5862
16
112
522
5400
Fever, unspecified
R50.9 [45582716]
1.8e-01
1.4e+00
—
—
—
2.9e+00
1.1e+00
cases:1.17%
controls:0.98%
cases:1.17%
controls:0.30%
—
—
—
—
—
—
cases:4.57%
controls:0.25%
cases:3.90%
controls:1.40%
7
58
591
5884
7
18
591
5924
—
—
—
27
15
564
5899
21
77
517
5435
pantoprazole; oral, parenteral
A02BC02 [21600097]
-1.5e-01
7.0e-02
—
—
1.9e+00
1.6e+00
4.8e-01
cases:8.36%
controls:9.61%
cases:5.02%
controls:4.70%
—
—
—
—
cases:6.37%
controls:0.98%
cases:19.97%
controls:4.95%
cases:17.66%
controls:11.70%
50
571
548
5371
30
279
568
5663
—
—
38
58
559
5884
118
293
473
5621
95
645
443
4867
Male infertility
N46 [45596868]
—
—
—
—
—
1.9e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.20%
cases:2.04%
controls:0.27%
—
—
—
—
—
8
12
583
5902
11
15
527
5497
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
7.4e-01
—
—
—
2.5e+00
1.5e+00
1.7e-01
cases:1.34%
controls:0.64%
—
—
—
—
—
—
cases:1.01%
controls:0.08%
cases:2.20%
controls:0.52%
cases:1.86%
controls:1.58%
8
38
590
5904
—
—
—
6
5
591
5937
13
31
578
5883
10
87
528
5425
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
7.4e-01
—
—
—
2.5e+00
1.5e+00
1.5e-01
cases:1.34%
controls:0.64%
—
—
—
—
—
—
cases:1.01%
controls:0.08%
cases:2.20%
controls:0.52%
cases:1.86%
controls:1.60%
8
38
590
5904
—
—
—
6
5
591
5937
13
31
578
5883
10
88
528
5424
Oncology Clinic/Center
261QX0200X [38004268]
—
—
—
1.0e+50
—
1.0e+50
3.9e+00
—
—
—
—
—
—
cases:99.67%
controls:0.00%
—
—
cases:0.85%
controls:0.00%
cases:4.46%
controls:0.09%
—
—
—
596
0
2
5942
—
5
0
586
5914
24
5
514
5507
Upper gastrointestinal surgery
106 [44777669]
1.3e-02
6.0e-01
2.0e+00
1.0e+50
1.4e+00
1.1e+00
7.4e-01
cases:5.35%
controls:5.28%
cases:3.34%
controls:1.87%
cases:2.17%
controls:0.29%
cases:0.84%
controls:0.00%
cases:1.17%
controls:0.29%
cases:5.58%
controls:1.86%
cases:11.52%
controls:5.84%
32
314
566
5628
20
111
578
5831
13
17
585
5925
5
0
593
5942
7
17
590
5925
33
110
558
5804
62
322
476
5190
Base excess in Arterial blood by calculation
1925-7 [3003396]
7.4e-01
—
—
—
2.5e+00
1.4e+00
1.7e-01
cases:1.34%
controls:0.64%
—
—
—
—
—
—
cases:1.01%
controls:0.08%
cases:2.20%
controls:0.54%
cases:1.86%
controls:1.58%
8
38
590
5904
—
—
—
6
5
591
5937
13
32
578
5882
10
87
528
5425
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
1.8e-01
4.0e-01
—
—
—
1.5e+00
2.4e+00
cases:1.17%
controls:0.98%
cases:1.00%
controls:0.67%
—
—
—
—
—
—
cases:3.21%
controls:0.73%
cases:11.34%
controls:1.20%
7
58
591
5884
6
40
592
5902
—
—
—
19
43
572
5871
61
66
477
5446
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
—
—
—
—
—
2.5e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.08%
cases:2.04%
controls:0.53%
—
—
—
—
—
6
5
585
5909
11
29
527
5483
enoxaparin; parenteral
B01AB05 [21600976]
1.5e-01
7.8e-01
—
—
—
2.7e+00
1.2e+00
cases:2.17%
controls:1.87%
cases:1.17%
controls:0.54%
—
—
—
—
—
—
cases:8.63%
controls:0.64%
cases:5.02%
controls:1.60%
13
111
585
5831
7
32
591
5910
—
—
—
51
38
540
5876
27
88
511
5424
Severe hypofunction of sexual glands
121 [2001600120]
—
—
—
—
—
—
3.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.09%
controls:0.09%
—
—
—
—
—
—
22
5
516
5507
Hematology
82 [38004501]
—
—
—
—
—
2.4e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.19%
cases:2.42%
controls:0.60%
—
—
—
—
—
12
11
579
5903
13
33
525
5479
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
96559-0 [36032269]
—
—
—
—
—
2.0e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:2.88%
controls:0.39%
cases:8.18%
controls:1.47%
—
—
—
—
—
17
23
574
5891
44
81
494
5431
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
-1.0e-01
-1.6e-01
—
—
3.2e+00
8.1e-01
5.5e-01
cases:6.02%
controls:6.61%
cases:1.67%
controls:1.95%
—
—
—
—
cases:2.51%
controls:0.10%
cases:3.38%
controls:1.54%
cases:8.92%
controls:5.37%
36
393
562
5549
10
116
588
5826
—
—
15
6
582
5936
20
91
571
5823
48
296
490
5216
codeine and paracetamol
N02AJ06 [1123647]
-2.5e-02
1.3e-01
1.5e+00
—
2.2e+00
3.8e-01
1.5e-01
cases:10.54%
controls:10.77%
cases:4.35%
controls:3.84%
cases:2.84%
controls:0.66%
—
—
cases:5.36%
controls:0.61%
cases:5.08%
controls:3.52%
cases:12.64%
controls:11.12%
63
640
535
5302
26
228
572
5714
17
39
581
5903
—
32
36
565
5906
30
208
561
5706
68
613
470
4899
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
1.9e-02
-2.4e-01
1.4e+00
—
2.4e+00
1.3e+00
3.9e-01
cases:2.68%
controls:2.63%
cases:1.51%
controls:1.90%
cases:1.17%
controls:0.30%
—
—
cases:3.69%
controls:0.35%
cases:6.60%
controls:1.83%
cases:7.99%
controls:5.53%
16
156
582
5786
9
113
589
5829
7
18
591
5924
—
22
21
575
5921
39
108
552
5806
43
305
495
5207
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
—
—
—
—
—
2.2e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.17%
cases:2.04%
controls:0.47%
—
—
—
—
—
9
10
582
5904
11
26
527
5486
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.3e+00
—
—
—
—
3.6e+00
9.5e-01
cases:0.84%
controls:0.22%
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.08%
cases:1.12%
controls:0.44%
5
13
593
5929
—
—
—
—
18
5
573
5909
6
24
532
5488
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
-2.0e-01
5.1e-01
2.5e+00
—
1.4e+00
1.1e+00
1.3e-01
cases:1.51%
controls:1.83%
cases:1.67%
controls:1.01%
cases:2.51%
controls:0.20%
—
—
cases:0.84%
controls:0.20%
cases:3.38%
controls:1.20%
cases:6.69%
controls:5.91%
9
109
589
5833
10
60
588
5882
15
12
583
5930
—
5
12
592
5930
20
71
571
5843
36
326
502
5186
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
—
—
—
—
—
3.6e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.88%
controls:0.08%
—
—
—
—
—
—
—
17
5
574
5909
—
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
3.6e-01
4.8e-01
2.4e+00
—
—
1.1e+00
-3.6e-01
cases:2.17%
controls:1.53%
cases:1.84%
controls:1.14%
cases:1.84%
controls:0.17%
—
—
—
—
cases:3.38%
controls:1.13%
cases:3.16%
controls:4.46%
13
91
585
5851
11
68
587
5874
11
10
587
5932
—
—
20
67
571
5847
17
246
521
5266
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
1.5e-01
6.3e-01
2.4e+00
—
1.7e+00
1.1e+00
-1.5e-01
cases:3.51%
controls:3.05%
cases:3.01%
controls:1.63%
cases:2.51%
controls:0.24%
—
—
cases:1.17%
controls:0.22%
cases:4.40%
controls:1.57%
cases:4.65%
controls:5.37%
21
181
577
5761
18
97
580
5845
15
14
583
5928
—
7
13
590
5929
26
93
565
5821
25
296
513
5216
dexamethasone; oral, parenteral
H02AB02 [21602730]
5.1e-01
—
—
—
—
3.3e+00
8.1e-01
cases:1.17%
controls:0.71%
—
—
—
—
—
—
—
—
cases:9.14%
controls:0.36%
cases:3.16%
controls:1.43%
7
42
591
5900
—
—
—
—
54
21
537
5893
17
79
521
5433
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.3e-02
6.3e-01
2.4e+00
—
1.3e+00
9.1e-01
-2.3e-03
cases:4.52%
controls:4.38%
cases:4.35%
controls:2.37%
cases:4.01%
controls:0.37%
—
—
cases:1.34%
controls:0.35%
cases:5.75%
controls:2.40%
cases:8.36%
controls:8.38%
27
260
571
5682
26
141
572
5801
24
22
574
5920
—
8
21
589
5921
34
142
557
5772
45
462
493
5050
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.3e+00
—
—
—
—
3.3e+00
1.1e+00
cases:1.00%
controls:0.29%
—
—
—
—
—
—
—
—
cases:4.91%
controls:0.19%
cases:1.86%
controls:0.62%
6
17
592
5925
—
—
—
—
29
11
562
5903
10
34
528
5478
Laceration/cut
S18 [2002000983]
-8.0e-02
1.0e-01
—
—
3.3e+00
7.0e-01
-1.1e-01
cases:4.85%
controls:5.23%
cases:1.84%
controls:1.67%
—
—
—
—
cases:5.70%
controls:0.22%
cases:3.55%
controls:1.79%
cases:5.76%
controls:6.40%
29
311
569
5631
11
99
587
5843
—
—
34
13
563
5929
21
106
570
5808
31
353
507
5159
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
5.8e-01
1.2e-01
3.3e+00
—
1.4e+00
8.1e-01
1.3e-01
cases:3.01%
controls:1.70%
cases:1.17%
controls:1.04%
cases:3.01%
controls:0.12%
—
—
cases:0.84%
controls:0.20%
cases:1.69%
controls:0.76%
cases:3.16%
controls:2.79%
18
101
580
5841
7
62
591
5880
18
7
580
5935
—
5
12
592
5930
10
45
581
5869
17
154
521
5358
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13967-5 [3004248]
—
—
—
—
—
1.8e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.52%
cases:8.74%
controls:2.18%
—
—
—
—
—
18
31
573
5883
47
120
491
5392
allopurinol; oral, parenteral
M04AA01 [21604131]
-6.5e-03
6.4e-01
—
—
1.9e+00
1.4e+00
2.0e-01
cases:1.34%
controls:1.35%
cases:1.67%
controls:0.89%
—
—
—
—
cases:1.84%
controls:0.29%
cases:4.23%
controls:1.12%
cases:2.23%
controls:1.83%
8
80
590
5862
10
53
588
5889
—
—
11
17
586
5925
25
66
566
5848
12
101
526
5411
Spirometry study
18759-1 [3000492]
—
—
—
—
—
2.4e+00
7.9e-01
—
—
—
—
—
—
—
—
—
—
cases:5.92%
controls:0.54%
cases:4.65%
controls:2.16%
—
—
—
—
—
35
32
556
5882
25
119
513
5393
pH of Urine
2756-5 [3015736]
-1.5e-02
4.5e-01
2.3e+00
—
1.1e+00
9.8e-01
-4.0e-03
cases:4.18%
controls:4.24%
cases:3.51%
controls:2.27%
cases:4.18%
controls:0.45%
—
—
cases:1.17%
controls:0.39%
cases:5.58%
controls:2.16%
cases:8.55%
controls:8.58%
25
252
573
5690
21
135
577
5807
25
27
573
5915
—
7
23
590
5919
33
128
558
5786
46
473
492
5039
Anaemia, unspecified
D64.9 [45600610]
—
—
—
—
—
3.2e+00
4.7e-01
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.08%
cases:0.93%
controls:0.58%
—
—
—
—
—
12
5
579
5909
5
32
533
5480
Bacterial infection, unspecified
A49.9 [45590816]
—
—
—
—
—
3.2e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:0.20%
cases:2.42%
controls:0.85%
—
—
—
—
—
28
12
563
5902
13
47
525
5465
prednisolone; oral, parenteral
H02AB06 [21602734]
4.0e-02
4.0e-01
7.3e-01
—
1.5e+00
1.6e+00
1.8e-01
cases:5.85%
controls:5.64%
cases:3.85%
controls:2.61%
cases:0.84%
controls:0.40%
—
—
cases:1.68%
controls:0.37%
cases:10.15%
controls:2.28%
cases:7.06%
controls:5.95%
35
335
563
5607
23
155
575
5787
5
24
593
5918
—
10
22
587
5920
60
135
531
5779
38
328
500
5184
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
7.6e-01
7.3e-01
—
—
—
3.1e+00
4.0e-01
cases:1.51%
controls:0.71%
cases:0.84%
controls:0.40%
—
—
—
—
—
—
cases:5.92%
controls:0.29%
cases:1.86%
controls:1.25%
9
42
589
5900
5
24
593
5918
—
—
—
35
17
556
5897
10
69
528
5443
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 [3013603]
2.6e-02
3.3e-01
2.0e+00
—
8.8e-01
6.7e-01
4.4e-01
cases:6.02%
controls:5.87%
cases:4.52%
controls:3.28%
cases:2.34%
controls:0.34%
—
—
cases:1.01%
controls:0.42%
cases:5.92%
controls:3.11%
cases:16.36%
controls:11.18%
36
349
562
5593
27
195
571
5747
14
20
584
5922
—
6
25
591
5917
35
184
556
5730
88
616
450
4896
prednisolone
A07EA01 [21600653]
2.7e-02
3.9e-01
7.3e-01
—
1.5e+00
1.6e+00
2.0e-01
cases:5.85%
controls:5.71%
cases:3.85%
controls:2.63%
cases:0.84%
controls:0.40%
—
—
cases:1.68%
controls:0.39%
cases:10.15%
controls:2.30%
cases:7.25%
controls:6.01%
35
339
563
5603
23
156
575
5786
5
24
593
5918
—
10
23
587
5919
60
136
531
5778
39
331
499
5181
Teaching
WZC30 [2001310891]
3.5e-02
—
—
—
—
3.0e+00
6.9e-01
cases:0.84%
controls:0.81%
—
—
—
—
—
—
—
—
cases:6.09%
controls:0.32%
cases:2.60%
controls:1.32%
5
48
593
5894
—
—
—
—
36
19
555
5895
14
73
524
5439
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
—
—
—
—
1.0e+50
3.0e+00
1.3e+00
—
—
—
—
—
—
—
—
cases:7.54%
controls:0.00%
cases:2.54%
controls:0.14%
cases:1.12%
controls:0.31%
—
—
—
—
45
0
552
5942
15
8
576
5906
6
17
532
5495
Infiltration anesthesia
WX110 [2001310767]
-1.7e-01
-1.4e-01
1.0e+00
—
1.3e+00
6.0e-01
4.5e-02
cases:15.38%
controls:17.75%
cases:5.52%
controls:6.28%
cases:2.68%
controls:0.98%
—
—
cases:2.85%
controls:0.77%
cases:10.83%
controls:6.27%
cases:19.52%
controls:18.81%
92
1055
506
4887
33
373
565
5569
16
58
582
5884
—
17
46
580
5896
64
371
527
5543
105
1037
433
4475
Physiotherapy
R4110 [2001310233]
-2.0e-01
4.6e-01
—
—
—
2.0e+00
8.8e-01
cases:2.17%
controls:2.64%
cases:1.51%
controls:0.96%
—
—
—
—
—
—
cases:5.25%
controls:0.73%
cases:5.02%
controls:2.14%
13
157
585
5785
9
57
589
5885
—
—
—
31
43
560
5871
27
118
511
5394
Clinic/Center
261Q00000X [38004207]
—
—
-1.0e+50
—
—
2.9e+00
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
cases:2.37%
controls:0.14%
—
—
—
—
0
5
598
5937
—
—
14
8
577
5906
—
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
-3.7e-01
-1.9e-01
1.2e+00
—
2.0e+00
8.8e-01
2.3e-01
cases:1.00%
controls:1.45%
cases:1.17%
controls:1.41%
cases:1.00%
controls:0.30%
—
—
cases:1.34%
controls:0.19%
cases:3.38%
controls:1.44%
cases:4.83%
controls:3.88%
6
86
592
5856
7
84
591
5858
6
18
592
5924
—
8
11
589
5931
20
85
571
5829
26
214
512
5298
Essential (primary) hypertension
I10 [45591453]
-4.9e-01
-4.9e-02
1.6e+00
—
1.2e+00
3.2e-01
8.6e-02
cases:4.35%
controls:6.93%
cases:3.18%
controls:3.33%
cases:2.01%
controls:0.40%
—
—
cases:2.01%
controls:0.61%
cases:5.08%
controls:3.75%
cases:11.71%
controls:10.85%
26
412
572
5530
19
198
579
5744
12
24
586
5918
—
12
36
585
5906
30
222
561
5692
63
598
475
4914
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
—
—
—
—
—
2.8e+00
7.5e-01
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.12%
cases:2.04%
controls:0.98%
—
—
—
—
—
11
7
580
5907
11
54
527
5458
Ultrasound examination of lower leg veins
PH2AE [2001309451]
1.5e-01
—
—
—
—
2.8e+00
8.7e-01
cases:0.84%
controls:0.72%
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.12%
cases:1.12%
controls:0.47%
5
43
593
5899
—
—
—
—
11
7
580
5907
6
26
532
5486
Testicular hypofunction
E29.1 [45576454]
—
-1.0e+50
—
—
—
1.8e+00
2.8e+00
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:1.02%
controls:0.17%
cases:5.20%
controls:0.34%
—
0
9
598
5933
—
—
—
6
10
585
5904
28
19
510
5493
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
—
—
—
—
1.0e+50
2.7e+00
1.3e+00
—
—
—
—
—
—
—
—
cases:7.71%
controls:0.00%
cases:2.54%
controls:0.17%
cases:1.30%
controls:0.34%
—
—
—
—
46
0
551
5942
15
10
576
5904
7
19
531
5493
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-1.1e-01
4.2e-02
—
—
1.9e+00
8.6e-01
3.2e-01
cases:3.34%
controls:3.74%
cases:2.17%
controls:2.09%
—
—
—
—
cases:2.01%
controls:0.32%
cases:5.25%
controls:2.30%
cases:9.11%
controls:6.79%
20
222
578
5720
13
124
585
5818
—
—
12
19
585
5923
31
136
560
5778
49
374
489
5138
One hour or less
ZXE00 [2001311394]
1.8e-01
3.1e-01
—
1.0e+50
—
1.7e+00
9.8e-01
cases:4.85%
controls:4.07%
cases:1.51%
controls:1.11%
—
—
cases:11.37%
controls:0.00%
—
—
cases:4.91%
controls:0.95%
cases:5.58%
controls:2.16%
29
242
569
5700
9
66
589
5876
—
68
0
530
5942
—
29
56
562
5858
30
119
508
5393
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.08%
—
—
—
—
—
—
—
7
5
584
5909
—
Thrombin time
3243-3 [3036489]
—
—
—
—
1.0e+50
2.6e+00
1.5e+00
—
—
—
—
—
—
—
—
cases:7.54%
controls:0.00%
cases:2.54%
controls:0.19%
cases:1.49%
controls:0.34%
—
—
—
—
45
0
552
5942
15
11
576
5903
8
19
530
5493
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
-1.0e+50
—
—
—
—
—
2.6e+00
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:2.23%
controls:0.16%
0
8
598
5934
—
—
—
—
—
12
9
526
5503
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
-3.3e-02
6.2e-01
2.6e+00
—
—
6.9e-04
-1.8e-01
cases:3.85%
controls:3.97%
cases:3.34%
controls:1.83%
cases:2.68%
controls:0.20%
—
—
—
—
cases:1.86%
controls:1.86%
cases:4.65%
controls:5.53%
23
236
575
5706
20
109
578
5833
16
12
582
5930
—
—
11
110
580
5804
25
305
513
5207
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
-2.7e-01
-3.6e-01
1.5e+00
—
1.1e+00
3.1e-01
4.9e-02
cases:9.87%
controls:12.49%
cases:5.18%
controls:7.27%
cases:3.85%
controls:0.91%
—
—
cases:2.35%
controls:0.77%
cases:9.48%
controls:7.12%
cases:24.16%
controls:23.28%
59
742
539
5200
31
432
567
5510
23
54
575
5888
—
14
46
583
5896
56
421
535
5493
130
1283
408
4229
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
—
—
—
1.0e+50
2.6e+00
9.9e-01
—
—
—
—
—
—
—
—
cases:7.71%
controls:0.00%
cases:2.20%
controls:0.17%
cases:1.12%
controls:0.42%
—
—
—
—
46
0
551
5942
13
10
578
5904
6
23
532
5489
Granulocytes [#/volume] in Blood
30394-1 [3035715]
—
-1.0e+50
—
—
—
2.6e+00
1.6e+00
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:1.52%
controls:0.12%
cases:0.93%
controls:0.18%
—
0
8
598
5934
—
—
—
9
7
582
5907
5
10
533
5502
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.9e-01
7.0e-02
2.6e+00
—
1.7e+00
7.6e-01
-7.9e-02
cases:4.18%
controls:3.48%
cases:1.84%
controls:1.72%
cases:1.51%
controls:0.12%
—
—
cases:1.01%
controls:0.19%
cases:3.55%
controls:1.69%
cases:5.58%
controls:6.01%
25
207
573
5735
11
102
587
5840
9
7
589
5935
—
6
11
591
5931
21
100
570
5814
30
331
508
5181
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
—
-1.0e+50
—
—
—
2.5e+00
1.2e+00
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
cases:1.69%
controls:0.14%
cases:0.93%
controls:0.27%
—
0
11
598
5931
—
—
—
10
8
581
5906
5
15
533
5497
Pathology report gross observation
24419-4 [3002256]
3.2e-01
—
—
1.0e+50
1.0e+50
2.5e+00
7.5e-01
cases:0.84%
controls:0.61%
—
—
—
—
cases:6.69%
controls:0.00%
cases:0.84%
controls:0.00%
cases:1.86%
controls:0.15%
cases:2.42%
controls:1.16%
5
36
593
5906
—
—
40
0
558
5942
5
0
592
5942
11
9
580
5905
13
64
525
5448
Respiratory and circulatory monitoring
WX700 [2001310817]
5.2e-02
—
—
1.0e+50
2.5e+00
1.2e+00
7.6e-01
cases:1.51%
controls:1.43%
—
—
—
—
cases:2.51%
controls:0.00%
cases:1.01%
controls:0.08%
cases:1.02%
controls:0.30%
cases:2.79%
controls:1.32%
9
85
589
5857
—
—
15
0
583
5942
6
5
591
5937
6
18
585
5896
15
73
523
5439
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
4.7e-02
5.6e-01
2.5e+00
—
—
7.6e-01
5.8e-01
cases:3.68%
controls:3.52%
cases:1.84%
controls:1.06%
cases:1.00%
controls:0.08%
—
—
—
—
cases:2.03%
controls:0.96%
cases:5.58%
controls:3.19%
22
209
576
5733
11
63
587
5879
6
5
592
5937
—
—
12
57
579
5857
30
176
508
5336
High resolution CT examination of lungs
GD1DD [2001303632]
—
-1.0e+50
—
—
—
2.5e+00
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:1.18%
controls:0.10%
—
—
—
0
6
598
5936
—
—
—
7
6
584
5908
—
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
4.5e-01
1.0e+00
—
—
—
2.5e+00
6.2e-01
cases:1.00%
controls:0.64%
cases:0.84%
controls:0.30%
—
—
—
—
—
—
cases:4.57%
controls:0.41%
cases:3.72%
controls:2.03%
6
38
592
5904
5
18
593
5924
—
—
—
27
24
564
5890
20
112
518
5400
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
4.8e-01
1.1e+00
—
—
—
2.5e+00
6.1e-01
cases:1.00%
controls:0.62%
cases:0.84%
controls:0.29%
—
—
—
—
—
—
cases:4.57%
controls:0.41%
cases:3.72%
controls:2.05%
6
37
592
5905
5
17
593
5925
—
—
—
27
24
564
5890
20
113
518
5399
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
—
—
—
—
—
2.4e+00
3.1e-01
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.17%
cases:1.12%
controls:0.82%
—
—
—
—
—
11
10
580
5904
6
45
532
5467
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
4.7e-02
5.6e-01
2.4e+00
—
-1.0e+50
-2.9e-02
-5.2e-02
cases:3.68%
controls:3.52%
cases:2.84%
controls:1.65%
cases:2.01%
controls:0.19%
—
—
cases:0.00%
controls:0.17%
cases:1.69%
controls:1.74%
cases:4.83%
controls:5.08%
22
209
576
5733
17
98
581
5844
12
11
586
5931
—
0
10
597
5932
10
103
581
5811
26
280
512
5232
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
5.9e-02
—
—
—
—
2.4e+00
5.4e-01
cases:1.34%
controls:1.26%
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.29%
cases:2.23%
controls:1.31%
8
75
590
5867
—
—
—
—
18
17
573
5897
12
72
526
5440
Localized enlarged lymph nodes
R59.0 [45534459]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.09%
—
—
—
—
—
—
5
5
533
5507
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.2e-01
8.8e-01
—
—
—
2.3e+00
6.2e-01
cases:1.00%
controls:0.89%
cases:1.17%
controls:0.49%
—
—
—
—
—
—
cases:5.92%
controls:0.61%
cases:5.02%
controls:2.76%
6
53
592
5889
7
29
591
5913
—
—
—
35
36
556
5878
27
152
511
5360
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
9.5e-01
—
—
—
—
2.3e+00
7.5e-01
cases:1.34%
controls:0.52%
—
—
—
—
—
—
—
—
cases:2.37%
controls:0.24%
cases:2.04%
controls:0.98%
8
31
590
5911
—
—
—
—
14
14
577
5900
11
54
527
5458
magnesium hydroxide; oral
G04BX01 [21602658]
—
-1.0e+50
—
—
—
2.3e+00
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:1.69%
controls:0.17%
—
—
—
0
8
598
5934
—
—
—
10
10
581
5904
—
magnesium hydroxide; oral
A02AA04 [21600052]
—
-1.0e+50
—
—
—
2.3e+00
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:1.69%
controls:0.17%
—
—
—
0
8
598
5934
—
—
—
10
10
581
5904
—
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
—
—
—
—
—
2.3e+00
5.0e-01
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.14%
cases:1.49%
controls:0.91%
—
—
—
—
—
8
8
583
5906
8
50
530
5462
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
—
—
—
—
—
2.3e+00
4.8e-01
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.14%
cases:1.49%
controls:0.93%
—
—
—
—
—
8
8
583
5906
8
51
530
5461
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
—
-1.0e+50
—
—
—
2.3e+00
1.4e+00
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:1.35%
controls:0.14%
cases:1.49%
controls:0.36%
—
0
6
598
5936
—
—
—
8
8
583
5906
8
20
530
5492
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
—
—
—
—
—
2.3e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.12%
cases:1.12%
controls:0.31%
—
—
—
—
—
7
7
584
5907
6
17
532
5495
pH of Specimen
17433-4 [3019225]
3.3e-01
—
—
—
2.1e+00
2.3e+00
5.4e-01
cases:1.00%
controls:0.72%
—
—
—
—
—
—
cases:0.84%
controls:0.10%
cases:4.74%
controls:0.49%
cases:2.23%
controls:1.31%
6
43
592
5899
—
—
—
5
6
592
5936
28
29
563
5885
12
72
526
5440
Removal of sutures from oral mucosa
SXB00 [2001310580]
—
-1.0e+50
—
—
—
2.3e+00
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:1.02%
controls:0.10%
—
—
—
0
8
598
5934
—
—
—
6
6
585
5908
—
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]
—
-1.0e+50
—
—
—
2.3e+00
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
cases:1.02%
controls:0.10%
—
—
—
0
7
598
5935
—
—
—
6
6
585
5908
—
Intensive care
WX872 [2001310844]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.10%
—
—
—
—
—
—
—
6
6
585
5908
—
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]
-1.4e-01
6.4e-01
2.3e+00
—
—
8.8e-01
2.0e-01
cases:2.17%
controls:2.49%
cases:2.34%
controls:1.25%
cases:1.34%
controls:0.13%
—
—
—
—
cases:3.05%
controls:1.29%
cases:6.69%
controls:5.55%
13
148
585
5794
14
74
584
5868
8
8
590
5934
—
—
18
76
573
5838
36
306
502
5206
calcium (different salts in combination); oral
A12AA20 [21600872]
4.7e-01
7.5e-01
—
—
—
1.2e+00
1.1e+00
cases:3.18%
controls:2.00%
cases:2.68%
controls:1.28%
—
—
—
—
—
—
cases:4.23%
controls:1.37%
cases:6.69%
controls:2.32%
19
119
579
5823
16
76
582
5866
—
—
—
25
81
566
5833
36
128
502
5384
prednisone; oral
H02AB07 [21602735]
3.0e-01
—
—
—
—
2.2e+00
7.2e-01
cases:0.84%
controls:0.62%
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.20%
cases:1.30%
controls:0.63%
5
37
593
5905
—
—
—
—
11
12
580
5902
7
35
531
5477
prednisone
A07EA03 [21600655]
3.0e-01
—
—
—
—
2.2e+00
7.2e-01
cases:0.84%
controls:0.62%
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.20%
cases:1.30%
controls:0.63%
5
37
593
5905
—
—
—
—
11
12
580
5902
7
35
531
5477
Ultrsound examination of soft tissue not elsewhere classified
QX2XE [2001310033]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.16%
0
7
598
5935
—
—
—
—
—
8
9
530
5503
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
7.7e-01
—
—
—
—
2.2e+00
7.2e-01
cases:0.84%
controls:0.39%
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.17%
cases:1.49%
controls:0.73%
5
23
593
5919
—
—
—
—
9
10
582
5904
8
40
530
5472
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
—
—
—
—
—
2.2e+00
7.1e-01
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.17%
cases:1.86%
controls:0.93%
—
—
—
—
—
9
10
582
5904
10
51
528
5461
Palliative care
Z51.5 [45547323]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.13%
—
—
—
—
—
—
6
7
532
5505
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
—
-1.0e+50
—
—
—
2.2e+00
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:1.18%
controls:0.14%
—
—
—
0
8
598
5934
—
—
—
7
8
584
5906
—
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
—
—
—
—
—
2.2e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.14%
cases:1.86%
controls:0.49%
—
—
—
—
—
7
8
584
5906
10
27
528
5485
Telephone prescription or other care instructions
WZB00 [2001310884]
-1.2e-01
2.0e-01
—
—
—
1.4e+00
8.2e-01
cases:4.85%
controls:5.44%
cases:1.34%
controls:1.09%
—
—
—
—
—
—
cases:5.08%
controls:1.35%
cases:7.06%
controls:3.25%
29
323
569
5619
8
65
590
5877
—
—
—
30
80
561
5834
38
179
500
5333
Other specified counselling
Z71.8 [45581061]
-6.8e-01
—
2.2e+00
—
—
2.9e-01
-1.6e-01
cases:1.34%
controls:2.61%
—
—
cases:1.17%
controls:0.13%
—
—
—
—
cases:2.03%
controls:1.52%
cases:4.83%
controls:5.61%
8
155
590
5787
—
7
8
591
5934
—
—
12
90
579
5824
26
309
512
5203
Oral Surgery
19 [38004464]
1.0e+00
—
—
—
—
2.2e+00
1.1e+00
cases:1.67%
controls:0.61%
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.24%
cases:1.86%
controls:0.60%
10
36
588
5906
—
—
—
—
12
14
579
5900
10
33
528
5479
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
—
—
—
—
—
2.2e+00
9.5e-01
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.12%
cases:1.30%
controls:0.51%
—
—
—
—
—
6
7
585
5907
7
28
531
5484
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
-1.3e-01
4.4e-01
—
—
—
2.1e+00
8.5e-01
cases:1.34%
controls:1.51%
cases:0.84%
controls:0.54%
—
—
—
—
—
—
cases:4.57%
controls:0.56%
cases:3.16%
controls:1.38%
8
90
590
5852
5
32
593
5910
—
—
—
27
33
564
5881
17
76
521
5436
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
—
—
—
—
—
2.1e+00
2.7e-01
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.30%
cases:1.67%
controls:1.29%
—
—
—
—
—
15
18
576
5896
9
71
529
5441
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
—
—
—
—
—
2.1e+00
6.2e-01
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.20%
cases:1.67%
controls:0.91%
—
—
—
—
—
10
12
581
5902
9
50
529
5462
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
—
—
—
—
—
2.1e+00
1.7e-01
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.25%
cases:1.12%
controls:0.94%
—
—
—
—
—
12
15
579
5899
6
52
532
5460
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
—
—
—
—
—
2.1e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.15%
cases:1.30%
controls:0.34%
—
—
—
—
—
7
9
584
5905
7
19
531
5493
nystatin; oral
A07AA02 [21600604]
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.15%
—
—
—
—
—
—
—
7
9
584
5905
—
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.22%
—
—
—
—
—
—
—
10
13
581
5901
—
Ultrasound examination of groin and abdominal wall
JA1AE [2001304364]
-1.0e+50
—
—
—
—
1.0e+50
2.0e+00
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.00%
cases:1.12%
controls:0.15%
0
5
598
5937
—
—
—
—
5
0
586
5914
6
8
532
5504
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
—
—
—
—
—
2.0e+00
4.0e-01
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.34%
cases:2.42%
controls:1.63%
—
—
—
—
—
15
20
576
5894
13
90
525
5422
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
—
—
—
—
—
2.0e+00
4.5e-01
—
—
—
—
—
—
—
—
—
—
cases:3.38%
controls:0.46%
cases:2.79%
controls:1.80%
—
—
—
—
—
20
27
571
5887
15
99
523
5413
potassium chloride; oral
A12BA01 [21600877]
—
9.7e-01
—
—
—
2.0e+00
1.1e+00
—
—
cases:0.84%
controls:0.32%
—
—
—
—
—
—
cases:2.37%
controls:0.32%
cases:1.86%
controls:0.63%
—
5
19
593
5923
—
—
—
14
19
577
5895
10
35
528
5477
Social worker
Z2446 [2001311559]
—
—
—
—
—
2.0e+00
1.0e+00
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.25%
cases:1.12%
controls:0.40%
—
—
—
—
—
11
15
580
5899
6
22
532
5490
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
—
—
—
—
1.0e+50
2.0e+00
6.5e-01
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.00%
cases:1.86%
controls:0.25%
cases:1.86%
controls:0.98%
—
—
—
—
5
0
592
5942
11
15
580
5899
10
54
528
5458
Estradiol (E2) [Moles/volume] in Serum or Plasma
14715-7 [3026725]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.24%
—
—
—
—
—
—
9
13
529
5499
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
—
—
—
—
—
2.0e+00
6.2e-01
—
—
—
—
—
—
—
—
—
—
cases:2.71%
controls:0.39%
cases:3.16%
controls:1.72%
—
—
—
—
—
16
23
575
5891
17
95
521
5417
Cathetrisation of vein
TPH04 [2001309597]
-2.5e-01
—
—
1.0e+50
2.3e+00
2.0e+00
2.8e-01
cases:1.34%
controls:1.72%
—
—
—
—
cases:2.34%
controls:0.00%
cases:0.84%
controls:0.08%
cases:4.40%
controls:0.64%
cases:2.97%
controls:2.27%
8
102
590
5840
—
—
14
0
584
5942
5
5
592
5937
26
38
565
5876
16
125
522
5387
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.22%
—
—
—
—
—
—
—
9
13
582
5901
—
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.22%
—
—
—
—
—
—
—
9
13
582
5901
—
Blasts/Leukocytes in Blood
26446-5 [3025159]
—
—
—
—
—
1.9e+00
5.5e-01
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.37%
cases:2.97%
controls:1.74%
—
—
—
—
—
15
22
576
5892
16
96
522
5416
ABO and Rh group [Type] in Blood
882-1 [3003694]
-3.1e-01
4.6e-02
—
1.0e+50
—
1.9e+00
2.0e-02
cases:1.84%
controls:2.49%
cases:1.34%
controls:1.28%
—
—
cases:1.17%
controls:0.00%
—
—
cases:3.89%
controls:0.59%
cases:3.53%
controls:3.47%
11
148
587
5794
8
76
590
5866
—
7
0
591
5942
—
23
35
568
5879
19
191
519
5321
Physiotherapist
Z3226 [2001311560]
-5.5e-01
—
—
—
—
1.9e+00
8.1e-01
cases:1.00%
controls:1.73%
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.25%
cases:1.30%
controls:0.58%
6
103
592
5839
—
—
—
—
10
15
581
5899
7
32
531
5480
loperamide oxide; oral
A07DA05 [21600648]
4.4e-01
—
—
—
-1.0e+50
1.9e+00
8.8e-01
cases:0.84%
controls:0.54%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:2.20%
controls:0.34%
cases:1.86%
controls:0.78%
5
32
593
5910
—
—
—
0
5
597
5937
13
20
578
5894
10
43
528
5469
loperamide; oral
A07DA03 [21600646]
4.4e-01
—
—
—
-1.0e+50
1.9e+00
8.8e-01
cases:0.84%
controls:0.54%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:2.20%
controls:0.34%
cases:1.86%
controls:0.78%
5
32
593
5910
—
—
—
0
5
597
5937
13
20
578
5894
10
43
528
5469
Gas panel - Venous blood
24339-4 [3000991]
—
—
—
—
2.1e+00
1.9e+00
6.8e-01
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.10%
cases:3.05%
controls:0.47%
cases:2.97%
controls:1.52%
—
—
—
—
5
6
592
5936
18
28
573
5886
16
84
522
5428
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
3.5e-02
—
—
—
—
1.9e+00
4.9e-01
cases:0.84%
controls:0.81%
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.29%
cases:2.42%
controls:1.49%
5
48
593
5894
—
—
—
—
11
17
580
5897
13
82
525
5430
General Practice Dentistry
1223G0001X [38003675]
—
-1.0e+50
—
—
—
1.9e+00
6.8e-01
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
cases:1.18%
controls:0.19%
cases:0.93%
controls:0.47%
—
0
16
598
5926
—
—
—
7
11
584
5903
5
26
533
5486
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
4.0e-01
—
—
—
—
1.9e+00
7.0e-01
cases:1.17%
controls:0.79%
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.32%
cases:2.42%
controls:1.22%
7
47
591
5895
—
—
—
—
12
19
579
5895
13
67
525
5445
tinzaparin; parenteral
B01AB10 [21600981]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.60%
controls:0.42%
—
—
—
—
—
—
14
23
524
5489
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
—
—
—
—
-1.0e+50
1.8e+00
5.9e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.27%
cases:2.23%
controls:1.25%
—
—
—
—
0
5
597
5937
10
16
581
5898
12
69
526
5443
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
—
—
—
—
—
1.8e+00
4.5e-01
—
—
—
—
—
—
—
—
—
—
cases:2.71%
controls:0.44%
cases:2.79%
controls:1.80%
—
—
—
—
—
16
26
575
5888
15
99
523
5413
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
—
1.3e+00
—
—
—
—
1.8e+00
—
—
cases:0.84%
controls:0.22%
—
—
—
—
—
—
—
—
cases:2.23%
controls:0.36%
—
5
13
593
5929
—
—
—
—
12
20
526
5492
Macroprolactin [Units/volume] in Serum or Plasma
74953-1 [44816844]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.27%
—
—
—
—
—
—
9
15
529
5497
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
6.9e-02
5.1e-01
—
—
—
1.8e+00
4.8e-01
cases:1.17%
controls:1.09%
cases:1.17%
controls:0.71%
—
—
—
—
—
—
cases:3.21%
controls:0.54%
cases:2.23%
controls:1.40%
7
65
591
5877
7
42
591
5900
—
—
—
19
32
572
5882
12
77
526
5435
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
-1.4e-01
—
—
—
1.0e+50
1.8e+00
5.9e-01
cases:0.84%
controls:0.96%
—
—
—
—
—
—
cases:1.01%
controls:0.00%
cases:2.37%
controls:0.41%
cases:2.23%
controls:1.25%
5
57
593
5885
—
—
—
6
0
591
5942
14
24
577
5890
12
69
526
5443
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
6.9e-02
—
—
—
—
1.8e+00
8.0e-01
cases:1.17%
controls:1.09%
—
—
—
—
—
—
—
—
cases:2.37%
controls:0.41%
cases:2.79%
controls:1.27%
7
65
591
5877
—
—
—
—
14
24
577
5890
15
70
523
5442
Pneumonia, unspecified
J18.9 [45601123]
6.0e-01
-1.0e+50
—
—
—
1.8e+00
4.4e-01
cases:3.34%
controls:1.87%
cases:0.00%
controls:0.54%
—
—
—
—
—
—
cases:3.21%
controls:0.56%
cases:3.90%
controls:2.54%
20
111
578
5831
0
32
598
5910
—
—
—
19
33
572
5881
21
140
517
5372
Infectious Disease
44 [38004484]
-1.0e-01
—
—
—
—
1.7e+00
5.5e-01
cases:1.34%
controls:1.48%
—
—
—
—
—
—
—
—
cases:3.38%
controls:0.61%
cases:2.97%
controls:1.74%
8
88
590
5854
—
—
—
—
20
36
571
5878
16
96
522
5416
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 [3001784]
-2.6e-01
3.9e-01
1.7e+00
—
—
6.4e-01
1.8e-01
cases:3.18%
controls:4.07%
cases:3.34%
controls:2.29%
cases:1.67%
controls:0.30%
—
—
—
—
cases:4.23%
controls:2.28%
cases:10.04%
controls:8.49%
19
242
579
5700
20
136
578
5806
10
18
588
5924
—
—
25
135
566
5779
54
468
484
5044
General anaesthesia
WX402 [2001310806]
—
—
—
1.0e+50
—
1.7e+00
6.5e-01
—
—
—
—
—
—
cases:9.87%
controls:0.00%
—
—
cases:3.21%
controls:0.59%
cases:5.20%
controls:2.79%
—
—
—
59
0
539
5942
—
19
35
572
5879
28
154
510
5358
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
3.5e-01
—
—
—
—
1.7e+00
5.0e-01
cases:0.84%
controls:0.59%
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.41%
cases:2.60%
controls:1.60%
5
35
593
5907
—
—
—
—
13
24
578
5890
14
88
524
5424
Right side
ZXA00 [2001311346]
-1.8e-01
—
—
—
—
1.7e+00
2.6e-01
cases:1.67%
controls:2.00%
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.47%
cases:2.04%
controls:1.58%
10
119
588
5823
—
—
—
—
15
28
576
5886
11
87
527
5425
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
—
—
—
—
—
1.7e+00
2.5e-01
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.32%
cases:1.30%
controls:1.02%
—
—
—
—
—
10
19
581
5895
7
56
531
5456
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
—
—
—
—
—
1.7e+00
-2.7e-01
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.42%
cases:1.12%
controls:1.45%
—
—
—
—
—
13
25
578
5889
6
80
532
5432
Medical doctor
Z2221 [2001311556]
2.0e-01
1.7e-01
2.1e+00
—
—
1.7e+00
5.9e-01
cases:4.01%
controls:3.32%
cases:1.17%
controls:0.99%
cases:0.84%
controls:0.10%
—
—
—
—
cases:3.05%
controls:0.59%
cases:2.23%
controls:1.25%
24
197
574
5745
7
59
591
5883
5
6
593
5936
—
—
18
35
573
5879
12
69
526
5443
Haemorrhage of anus and rectum
K62.5 [45596339]
-1.0e+50
-1.0e+50
—
—
—
—
1.6e+00
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.33%
0
9
598
5933
0
6
598
5936
—
—
—
—
9
18
529
5494
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
-1.7e-01
—
—
—
—
1.6e+00
5.1e-01
cases:1.17%
controls:1.38%
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.37%
cases:2.79%
controls:1.69%
7
82
591
5860
—
—
—
—
11
22
580
5892
15
93
523
5419
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
—
—
-1.0e+50
—
—
1.6e+00
7.6e-01
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.86%
controls:0.37%
cases:2.23%
controls:1.05%
—
—
0
6
598
5936
—
—
11
22
580
5892
12
58
526
5454
Specific gravity of Urine by Refractometry
5810-7 [3019150]
-6.6e-03
4.1e-01
1.6e+00
—
-1.0e+50
5.9e-01
-1.1e-01
cases:2.68%
controls:2.69%
cases:2.34%
controls:1.57%
cases:1.34%
controls:0.27%
—
—
cases:0.00%
controls:0.24%
cases:2.54%
controls:1.42%
cases:4.83%
controls:5.35%
16
160
582
5782
14
93
584
5849
8
16
590
5926
—
0
14
597
5928
15
84
576
5830
26
295
512
5217
Oxygen saturation in Arterial blood
2708-6 [3016502]
7.7e-01
—
—
—
2.3e+00
1.6e+00
-1.7e-01
cases:0.84%
controls:0.39%
—
—
—
—
—
—
cases:0.84%
controls:0.08%
cases:2.20%
controls:0.46%
cases:1.30%
controls:1.54%
5
23
593
5919
—
—
—
5
5
592
5937
13
27
578
5887
7
85
531
5427
valaciclovir; oral
J05AB11 [21603137]
6.1e-01
—
—
—
—
1.6e+00
7.1e-01
cases:1.84%
controls:1.01%
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.36%
cases:2.42%
controls:1.20%
11
60
587
5882
—
—
—
—
10
21
581
5893
13
66
525
5446
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
2.2e-02
2.2e-01
—
—
—
1.6e+00
8.2e-02
cases:6.35%
controls:6.23%
cases:2.01%
controls:1.62%
—
—
—
—
—
—
cases:6.09%
controls:1.35%
cases:6.13%
controls:5.68%
38
370
560
5572
12
96
586
5846
—
—
—
36
80
555
5834
33
313
505
5199
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
3.1e-01
—
—
—
—
1.5e+00
5.1e-01
cases:1.00%
controls:0.74%
—
—
—
—
—
—
—
—
cases:2.88%
controls:0.63%
cases:3.16%
controls:1.92%
6
44
592
5898
—
—
—
—
17
37
574
5877
17
106
521
5406
Base excess in Venous blood by calculation
1927-3 [3002032]
3.1e-01
—
—
—
—
1.5e+00
5.0e-01
cases:1.00%
controls:0.74%
—
—
—
—
—
—
—
—
cases:2.88%
controls:0.63%
cases:3.16%
controls:1.94%
6
44
592
5898
—
—
—
—
17
37
574
5877
17
107
521
5405
Dentistry
C5 [903277]
-2.4e-01
—
-1.0e+50
—
—
1.5e+00
1.6e-01
cases:1.34%
controls:1.70%
—
—
cases:0.00%
controls:0.13%
—
—
—
—
cases:1.69%
controls:0.37%
cases:2.60%
controls:2.23%
8
101
590
5841
—
0
8
598
5934
—
—
10
22
581
5892
14
123
524
5389
pH of Venous blood
2746-6 [3012544]
4.9e-01
—
—
—
—
1.5e+00
5.0e-01
cases:1.17%
controls:0.72%
—
—
—
—
—
—
—
—
cases:2.88%
controls:0.64%
cases:3.35%
controls:2.05%
7
43
591
5899
—
—
—
—
17
38
574
5876
18
113
520
5399
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
-6.3e-02
—
—
—
—
1.5e+00
4.6e-01
cases:1.17%
controls:1.25%
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.57%
cases:2.79%
controls:1.78%
7
74
591
5868
—
—
—
—
15
34
576
5880
15
98
523
5414
ECG with 12 standard connections
XF400 [2001303368]
6.9e-02
—
—
—
—
1.5e+00
6.2e-01
cases:1.17%
controls:1.09%
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.39%
cases:1.67%
controls:0.91%
7
65
591
5877
—
—
—
—
10
23
581
5891
9
50
529
5462
omeprazole; oral, parenteral
A02BC01 [21600096]
8.6e-02
4.5e-02
—
—
1.3e+00
1.5e+00
4.0e-01
cases:2.51%
controls:2.31%
cases:1.00%
controls:0.96%
—
—
—
—
cases:0.84%
controls:0.24%
cases:4.40%
controls:1.05%
cases:3.53%
controls:2.39%
15
137
583
5805
6
57
592
5885
—
—
5
14
592
5928
26
62
565
5852
19
132
519
5380
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
5.0e-01
—
—
—
—
1.5e+00
2.0e-01
cases:2.01%
controls:1.23%
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.44%
cases:2.42%
controls:1.98%
12
73
586
5869
—
—
—
—
11
26
580
5888
13
109
525
5403
pH of Arterial blood
2744-1 [3019977]
8.0e-01
—
—
—
—
1.5e+00
1.8e-01
cases:1.34%
controls:0.61%
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.52%
cases:1.86%
controls:1.56%
8
36
590
5906
—
—
—
—
13
31
578
5883
10
86
528
5426
Monitored bed care
WX892 [2001310850]
—
—
—
—
—
1.6e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.25%
cases:2.04%
controls:0.49%
—
—
—
—
—
7
15
584
5899
11
27
527
5485
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
-1.0e+50
—
—
—
—
—
1.4e+00
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
cases:3.35%
controls:0.82%
0
29
598
5913
—
—
—
—
—
18
45
520
5467
Vascular Surgery
77 [38004496]
-5.4e-01
—
—
—
—
1.4e+00
4.4e-01
cases:0.84%
controls:1.43%
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.46%
cases:2.04%
controls:1.32%
5
85
593
5857
—
—
—
—
11
27
580
5887
11
73
527
5439
sulfadiazine and trimethoprim
J01EE02 [21602962]
-6.6e-02
1.1e+00
—
—
—
1.4e+00
4.8e-01
cases:1.67%
controls:1.78%
cases:1.17%
controls:0.40%
—
—
—
—
—
—
cases:1.69%
controls:0.42%
cases:2.60%
controls:1.63%
10
106
588
5836
7
24
591
5918
—
—
—
10
25
581
5889
14
90
524
5422

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
186
12
215.94
307.65
11.0
1.2
509.42
—
pmol/l
—
124
0
186
133
19.12
212.66
1.2
1.3
—
—
—
0
0
163
105
20.33
195.87
3.6
1.4
16.25
7.46
iu/l
5.37
124
80
211
251
11.92
174.07
3.3
1.5
7.79
4.00
u/l
6.82
171
207
325
1084
4.96
90.80
4.7
2.5
13.26
15.50
nmol/l
6.98
314
1014
480
2317
4.99
79.19
10.7
4.8
11.07
12.96
umol/l
3.60
475
2222
207
573
4.82
70.79
1.4
1.7
—
—
—
0
0
302
1266
3.57
55.39
2.1
1.6
—
—
—
0
0
236
858
3.73
53.69
1.6
1.6
—
—
—
0
0
563
3624
4.90
50.72
13.8
6.5
76.75
75.77
u/l
0.27
557
3457
229
856
3.57
49.34
1.7
1.8
—
—
—
0
0
471
2720
3.59
49.32
13.4
9.0
3.70
4.19
e9/l
4.17
421
2369
276
1235
3.13
43.21
5.7
2.2
2.36
2.35
mmol/l
0.63
256
1116
49
9
58.66
42.07
8.7
2.1
3.63
3.67
ug/l
—
49
9
181
662
3.39
39.29
5.8
2.0
2.44
2.42
mmol/l
1.70
164
584
342
1882
2.71
34.34
9.6
4.8
36.51
37.04
g/l
0.89
321
1758
327
1763
2.70
34.17
3.1
2.6
—
—
estimate
—
0
0
259
1268
2.72
32.44
2.0
2.1
—
—
—
0
0
117
376
3.57
30.56
1.3
1.1
—
—
—
0
0
389
2372
2.57
30.31
6.8
7.1
26.58
28.44
%
2.68
374
2281
252
1254
2.64
30.12
1.4
1.3
—
—
—
0
0
243
1191
2.65
29.92
3.4
2.9
0.50
0.28
e6/l
0.45
182
853
376
2272
2.53
29.63
6.8
7.1
2.78
3.04
%
1.32
362
2167
377
2282
2.53
29.58
7.0
7.3
9.19
9.10
%
0.23
362
2176
376
2275
2.53
29.50
7.0
7.3
0.70
0.69
%
0.19
362
2174
356
2101
2.52
29.47
10.6
7.4
1.20
1.20
mmol/l
0.40
291
1836
235
1141
2.65
29.40
3.4
2.8
—
0.00
estimate
—
0
7
72
167
4.72
29.33
5.8
2.2
4.29
2.54
ug/l
1.96
57
134
268
1389
2.57
29.27
3.7
3.0
56.59
115.58
e6/l
0.43
205
1047
322
1846
2.46
27.96
9.3
7.2
1.21
1.20
mmol/l
0.39
315
1709
49
88
5.94
26.54
3.3
6.7
10.14
8.50
%
0.95
49
88
49
88
5.94
26.54
1.6
3.4
41.78
45.94
%
0.62
49
88
375
2338
2.41
26.51
6.6
7.0
57.69
56.41
%
1.24
365
2272
420
2757
2.45
26.37
6.4
5.6
6.64
6.79
mmol/l
0.67
406
2649
284
1582
2.40
25.75
4.2
3.5
32.76
89.30
e6/l
1.11
213
1120
355
2183
2.36
25.59
12.8
10.2
0.00
0.00
e9/l
0.46
286
1799
398
2588
2.37
24.97
6.6
7.1
1.66
1.92
e9/l
7.55
342
2292
236
1232
2.43
24.52
3.0
2.4
—
—
—
0
0
389
2518
2.34
24.48
6.5
7.0
0.60
0.60
e9/l
0.23
323
2193
388
2518
2.32
24.14
6.5
7.0
0.04
0.04
e9/l
2.36
323
2198
237
1253
2.40
23.80
6.7
4.2
—
—
—
0
0
392
2582
2.29
23.16
6.8
7.4
0.17
0.21
e9/l
4.16
333
2273
219
1136
2.39
22.79
5.4
4.3
91.58
87.31
%
2.05
214
1119
155
686
2.65
22.64
3.3
2.7
0.39
0.55
e6/l
0.39
86
321
161
737
2.57
21.88
3.1
2.7
0.90
0.87
e6/l
0.03
95
373
322
2023
2.16
20.55
15.7
14.8
1.23
1.26
inr
0.64
274
1700
228
1255
2.25
20.23
3.6
2.5
363.31
376.82
umol/l
1.41
215
1139
214
1190
2.18
18.18
6.8
3.6
7.40
7.39
ph
0.76
163
837
187
1006
2.20
17.11
1.8
1.9
1.19
0.99
mg/l
0.62
139
724
159
809
2.27
16.61
3.1
2.5
587.65
571.63
mosm/kgh2o
0.36
143
702
175
936
2.19
16.13
3.0
2.5
2.89
2.24
e6/l
0.55
158
854
15
0
+∞
15.68
6.7
0.0
0.33
—
umol/l
—
15
0
597
5113
2.86
14.21
25.5
14.8
139.48
139.80
mmol/l
3.44
589
5008
223
1358
1.97
14.20
10.3
5.5
—
—
—
0
0
597
5134
2.81
13.69
25.9
14.8
3.99
4.00
mmol/l
0.67
587
5020
130
668
2.18
12.99
9.7
9.3
104.58
104.34
mmol/l
0.28
130
668
593
5167
2.54
11.67
23.0
12.3
23.57
25.02
mg/l
0.52
515
4082
34
94
3.76
10.93
2.6
3.8
57.59
57.55
%
0.01
34
94
76
341
2.39
10.38
5.2
3.9
7.38
7.34
ph
2.06
69
263
17
13
13.39
10.20
1.2
1.0
—
—
—
0
0
29
78
3.84
9.70
2.7
4.3
4.03
4.27
e9/l
0.22
29
78
127
716
1.96
9.69
3.3
2.6
12.86
14.61
umol/l
1.96
118
665
111
619
1.95
8.69
3.5
2.6
24.18
25.80
%
0.68
103
578
84
437
2.06
7.97
11.6
12.1
—
—
—
0
0
16
19
8.60
7.85
1.1
1.5
—
—
—
0
0
70
342
2.17
7.81
2.9
2.6
62.88
68.74
e9/l
0.74
52
244
58
264
2.31
7.66
10.7
16.6
16.42
16.60
%
0.16
58
255
115
675
1.85
7.66
3.4
2.6
2.26
2.27
g/l
0.05
106
627
86
459
2.01
7.60
3.5
2.7
1.75
1.73
%
0.05
79
417
19
31
6.28
7.59
1.3
1.1
—
—
—
0
0
307
2356
1.57
7.34
3.3
3.1
0.01
8.11
estimate
0.80
80
451
15
19
8.05
7.13
1.1
1.2
—
—
—
0
0
114
683
1.81
7.09
3.0
2.6
—
—
—
0
0
66
330
2.11
6.95
3.5
3.3
—
—
—
0
0
302
2332
1.55
6.88
3.4
3.1
0.00
0.00
estimate
-0.00
81
455
90
507
1.90
6.79
1.9
2.2
—
—
—
0
0
509
4446
1.65
6.52
30.0
15.0
13.52
13.28
%
4.12
503
4386
304
2370
1.53
6.52
3.4
3.1
0.00
0.02
estimate
0.79
73
402
113
708
1.72
5.98
2.1
2.2
—
—
—
0
0
76
426
1.89
5.81
4.1
5.0
2.04
0.67
%
2.27
38
105
88
517
1.81
5.80
5.4
2.4
13.44
8.83
umol/l
0.58
78
460
108
674
1.72
5.79
1.9
1.5
—
—
—
0
0
73
410
1.88
5.55
4.0
4.9
1.14
0.37
%
1.44
35
104
189
1376
1.52
5.36
3.2
2.5
0.00
0.00
estimate
-0.00
63
350
251
1943
1.47
5.26
3.0
3.0
6.17
6.13
ph
0.33
147
1157
343
2821
1.45
5.22
4.7
3.5
2.32
1.58
ug/l
0.58
306
2580
77
452
1.80
5.09
3.8
2.6
29.71
140.84
u/l
0.54
62
390
199
1482
1.49
5.02
3.4
2.7
54.40
62.02
u/l
1.34
183
1400
31
130
2.45
4.96
1.5
1.3
—
—
—
0
0
86
536
1.70
4.62
5.3
3.7
7.36
7.38
ph
1.23
62
316
25
98
2.61
4.60
1.6
1.4
243.57
304.49
ug/g
0.54
14
56
587
5450
1.73
4.52
22.0
10.5
—
—
—
0
0
43
216
2.06
4.52
1.7
1.3
—
—
—
0
0
70
415
1.77
4.49
4.1
5.1
0.34
0.06
%
1.47
32
94
71
423
1.76
4.48
4.4
5.3
0.22
0.00
%
1.16
32
87
29
124
2.40
4.47
1.3
1.3
155.00
144.13
au/ml
0.30
12
39
16
50
3.25
4.36
1.6
1.2
—
—
—
0
0
86
548
1.66
4.25
10.5
11.4
0.76
1.11
mmol/l
0.48
74
452
14
41
3.47
4.20
2.6
2.5
0.53
0.80
e9/l
1.59
14
41
86
553
1.64
4.11
10.6
11.5
7.42
7.41
ph
0.06
41
311
81
517
1.65
3.98
5.5
3.7
1.41
1.72
mmol/l
0.42
72
441
16
54
3.01
3.87
2.1
1.8
—
—
—
0
0
16
54
3.01
3.87
2.1
1.8
—
—
—
0
0
16
54
3.01
3.87
2.1
1.8
—
—
—
0
0
16
54
3.01
3.87
2.1
1.8
—
—
—
0
0
231
1845
1.39
3.80
3.3
3.0
0.00
0.00
estimate
-0.00
73
384
14
45
3.16
3.67
2.1
2.6
37.02
39.69
%
0.36
14
45
81
532
1.60
3.56
5.5
3.7
5.85
5.92
kpa
0.27
81
514
164
1248
1.42
3.54
3.5
3.4
1088.46
1370.56
ng/l
0.60
139
1034
25
113
2.26
3.45
4.7
3.9
—
—
—
0
0
71
456
1.62
3.42
12.1
13.0
120.99
128.17
g/l
1.90
71
444
137
1015
1.44
3.42
2.5
2.2
2.93
2.74
mg/l
0.41
118
868
25
114
2.24
3.39
1.1
1.2
—
—
—
0
0
24
108
2.27
3.36
3.3
2.4
130.81
137.52
g/l
0.45
16
83
55
333
1.71
3.32
3.9
3.3
7.41
7.41
ph
0.24
46
286
6
7
8.64
3.27
2.7
1.1
11.00
11.79
u/l
—
6
7
13
43
3.06
3.26
2.2
1.6
1.20
0.97
%
—
6
29
16
60
2.71
3.25
1.1
1.1
—
—
—
0
0
620
5926
1.84
3.24
36.2
18.2
233.52
238.75
e9/l
1.53
606
5815
12
34
3.58
3.21
1.3
1.0
—
—
—
0
0
26
124
2.14
3.18
3.0
1.7
—
—
—
0
0
15
55
2.77
3.17
1.5
1.7
244.40
268.00
mu/l
0.22
15
45
68
442
1.60
3.14
2.3
1.8
368.95
363.05
nmol/l
0.10
62
411
620
5934
1.82
3.11
36.1
18.1
4.67
4.82
e12/l
9.04
604
5817
36
196
1.89
3.08
2.4
3.2
4.82
4.79
pmol/l
0.03
31
178
620
5938
1.80
3.04
36.2
18.2
6.38
6.61
e9/l
2.16
605
5822
36
197
1.88
3.04
6.5
7.0
1.66
0.85
%
0.53
36
184
10
26
3.89
2.99
1.1
1.7
—
—
—
0
0
75
506
1.54
2.96
1.6
1.5
—
—
—
0
0
153
1190
1.37
2.86
5.7
5.1
—
—
—
0
0
221
1821
1.32
2.82
4.8
3.2
36.23
37.22
u/l
0.10
213
1723
37
211
1.80
2.77
1.5
1.3
—
—
—
0
0
5
6
8.38
2.75
1.0
1.3
—
—
mmol/l
—
0
0
84
591
1.48
2.73
1.8
1.8
—
—
—
0
0
15
60
2.54
2.72
1.5
1.2
—
—
—
0
0
40
236
1.74
2.68
3.0
3.3
—
—
—
0
0
79
552
1.49
2.66
1.2
1.3
—
—
—
0
0
38
222
1.76
2.63
4.4
3.1
23.86
25.03
mmol/l
1.49
38
211
14
55
2.58
2.63
3.2
2.7
—
—
—
0
0
199
1630
1.32
2.62
2.8
2.5
0.69
0.69
ug/l
0.02
124
853
45
278
1.66
2.57
1.2
1.2
—
—
—
0
0
6
11
5.49
2.55
1.3
1.2
—
—
—
0
0
19
88
2.19
2.53
4.0
3.3
—
—
—
0
0
13
52
2.53
2.37
2.3
3.6
—
—
—
0
0
11
39
2.85
2.35
1.3
1.2
11.80
27.57
%
—
5
30
25
133
1.91
2.34
1.1
1.1
—
—
—
0
0
54
359
1.55
2.31
3.5
2.2
0.46
0.26
e6/l
0.27
54
342
151
1212
1.32
2.27
3.4
3.3
0.03
0.01
estimate
0.27
72
408
9
29
3.13
2.23
1.3
1.2
—
—
—
0
0
5
9
5.59
2.21
1.0
1.0
—
—
—
0
0
5
9
5.59
2.21
1.2
1.0
—
—
—
0
0
13
54
2.44
2.21
1.2
1.1
—
—
—
0
0
36
219
1.68
2.20
6.5
6.5
1.69
1.65
%
0.08
36
205
7
19
3.71
2.15
1.9
1.8
5.43
6.95
%
—
7
19
7
19
3.71
2.15
1.9
1.8
43.71
28.68
%
—
7
19
19
95
2.03
2.12
9.2
11.3
10.84
11.86
mmol/l
0.92
19
86
19
95
2.03
2.12
9.2
11.3
103.79
105.74
mmol/l
1.19
19
86
89
666
1.39
2.10
2.0
1.8
1059.20
1161.30
nmol/l
0.58
64
528
16
75
2.16
2.10
2.3
1.3
6.33
4.24
u/ml
—
9
42
42
270
1.59
2.09
7.0
4.6
121.15
101.04
ng/l
0.63
34
240
9
31
2.93
2.08
1.4
1.2
—
—
—
0
0
28
164
1.74
1.98
1.2
1.2
249.15
257.71
u/ml
0.06
20
96
5
11
4.57
1.94
1.0
1.9
—
—
—
0
0
16
78
2.08
1.92
4.6
4.1
12.75
11.38
pmol/l
0.11
16
78
220
1889
1.25
1.91
4.1
3.5
45.89
51.45
ng/l
0.12
164
1246
223
1921
1.24
1.87
2.0
1.9
94.28
95.60
pmol/l
0.17
133
1103
5
12
4.19
1.82
2.0
2.3
0.62
0.62
mmol/l
—
5
12
8
29
2.78
1.79
3.1
2.5
81.63
147.72
e6/l
—
8
29
13
60
2.19
1.78
1.2
1.3
—
—
—
0
0
18
95
1.92
1.77
2.4
1.2
1.54
1.40
ratio
—
10
48
62
454
1.40
1.69
5.0
3.1
5.07
4.60
kpa
0.89
62
436
25
150
1.69
1.65
4.0
3.6
66.34
64.01
%
0.21
25
145
15
276
0.53
1.65
1.0
1.2
—
—
—
0
0
9
37
2.45
1.48
2.0
2.3
—
—
—
0
0
39
269
1.48
1.48
1.2
1.2
—
—
—
0
0
374
3452
1.19
1.45
3.4
3.0
14.91
14.86
pmol/l
0.14
339
3172
20
118
1.72
1.42
1.3
1.4
128.06
191.90
pmol/l
1.13
20
118
10
47
2.15
1.34
1.7
1.5
32.18
28.22
g/l
—
10
40
0
40
0.00
1.33
0.0
1.1
—
8.88
—
0
9
135
1141
1.23
1.33
1.6
1.6
18.20
18.60
nmol/l
0.13
117
1001
21
129
1.65
1.31
1.1
1.2
852.81
517.85
mg/l
0.67
21
121
16
91
1.78
1.30
4.5
3.0
7.00
7.15
mmol/l
0.10
16
86
24
154
1.58
1.27
1.0
1.2
—
—
—
0
0
8
35
2.30
1.27
1.9
1.5
22.90
28.69
ng/l
—
8
35
18
107
1.70
1.27
1.2
1.2
3.51
3.85
mmol/l
0.61
18
99
19
115
1.67
1.26
4.1
2.8
1.35
1.55
mmol/l
0.99
19
107
8
36
2.24
1.24
15.8
4.2
0.50
1.03
index
—
8
36
12
63
1.92
1.23
1.2
1.1
—
—
—
0
0
521
5406
0.82
1.19
5.1
5.1
2.79
2.80
mmol/l
0.11
493
5153
6
26
2.32
1.19
1.5
1.8
—
—
—
0
0
8
39
2.06
1.15
1.8
1.5
—
—
—
0
0
27
183
1.50
1.15
2.4
2.6
222.30
701.08
ug/l
1.25
27
178
12
65
1.86
1.14
1.8
2.4
10.90
10.55
%
0.09
12
65
10
51
1.98
1.11
1.3
1.5
—
—
—
0
0
12
66
1.83
1.09
1.8
2.2
19.83
21.96
nmol/l
0.35
12
59
5
21
2.39
1.09
1.4
1.3
—
—
—
0
0
5
21
2.39
1.09
1.8
2.0
0.00
0.14
estimate
—
5
21
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
8
41
1.96
1.09
1.5
1.1
—
—
—
0
0
45
587
0.75
1.08
2.6
3.3
—
—
—
0
0
45
586
0.75
1.07
2.4
2.9
—
—
—
0
0
24
162
1.50
1.05
2.8
2.2
—
—
—
0
0
45
583
0.76
1.04
2.4
3.3
—
—
—
0
0
516
5334
0.85
0.96
4.7
4.6
1.25
1.28
mmol/l
1.11
485
5080
45
575
0.77
0.95
2.3
3.1
—
—
—
0
0
488
5065
0.86
0.95
4.0
4.0
1.47
1.40
mmol/l
1.09
454
4802
519
5358
0.85
0.92
4.7
4.6
4.59
4.58
mmol/l
0.09
490
5132
234
2546
0.87
0.90
3.1
2.9
—
—
—
0
0
12
71
1.70
0.89
1.3
2.2
4.30
5.43
mmol/24h
0.79
12
63
43
547
0.77
0.89
2.4
3.4
—
—
—
0
0
6
30
2.01
0.87
1.3
1.7
—
22.88
—
0
5
109
948
1.18
0.82
4.1
3.7
457.86
799.86
ng/l
0.77
86
695
16
105
1.54
0.82
1.2
1.2
—
—
—
0
0
25
339
0.73
0.81
2.6
2.5
31.32
13.94
au/ml
—
5
49
0
24
0.00
0.79
0.0
2.0
—
—
—
0
0
6
33
1.83
0.79
1.0
1.3
—
—
—
0
0
0
25
0.00
0.79
0.0
1.7
—
148.98
—
0
20
22
158
1.41
0.75
2.8
3.4
263.00
401.93
mg/l
0.44
11
81
79
674
1.20
0.75
1.3
1.4
393.85
318.71
titre
0.28
13
124
459
4416
1.13
0.74
4.2
3.8
1.82
1.86
mu/l
0.34
419
4093
14
92
1.53
0.72
2.5
2.2
0.87
1.10
g/l
0.33
14
71
219
2022
1.12
0.72
3.8
2.7
181.56
163.09
ug/l
0.64
200
1899
21
152
1.39
0.70
1.8
2.7
14.36
10.51
mg/l
0.99
21
143
24
178
1.36
0.69
1.1
1.1
—
—
—
0
0
475
4904
0.89
0.69
6.1
5.6
38.86
38.91
mmol/mol
0.04
441
4692
20
144
1.40
0.68
1.4
1.1
—
—
—
0
0
18
127
1.43
0.68
11.1
3.3
3.54
2.29
index
0.52
13
78
5
28
1.79
0.66
3.8
5.4
—
—
—
0
0
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
3.74
—
0
6
13
185
0.70
0.59
1.9
1.8
14.80
16.34
u/ml
—
6
62
17
230
0.73
0.58
3.1
5.3
—
—
—
0
0
57
665
0.84
0.57
1.2
1.3
3.20
6.97
u/ml
0.84
13
274
16
218
0.73
0.57
1.2
1.5
—
—
—
0
0
428
4133
1.10
0.56
3.9
3.4
56.88
47.76
u/l
1.25
412
3976
6
39
1.54
0.53
1.8
1.3
—
—
—
0
0
9
63
1.43
0.52
1.2
1.1
241.22
260.26
mg/l
—
9
57
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
17
127
1.35
0.50
1.9
1.6
—
—
—
0
0
12
84
1.44
0.49
1.2
1.4
—
—
—
0
0
7
46
1.53
0.48
1.0
1.2
272.86
286.78
mg/l
—
7
36
7
46
1.53
0.48
2.0
1.3
275.43
285.65
mosm/kgh2o
—
7
31
10
68
1.48
0.47
1.1
1.1
—
—
—
0
0
12
85
1.42
0.47
1.0
1.1
—
—
—
0
0
35
292
1.21
0.46
6.8
6.3
—
—
—
0
0
7
49
1.43
0.46
1.0
1.2
55.71
43.27
mg/l
—
7
38
67
751
0.88
0.43
1.3
1.3
12.58
22.75
iu/ml
2.91
17
213
5
33
1.52
0.41
1.2
1.3
0.56
0.52
e9/l
—
5
33
38
324
1.18
0.41
2.3
1.9
0.00
0.00
estimate
—
10
85
110
1011
1.11
0.41
1.5
1.4
2.58
2.66
g/l
0.16
76
702
104
1132
0.90
0.41
1.3
1.3
4.21
1.75
u/ml
0.44
27
359
5
35
1.43
0.39
1.0
1.4
5.72
6.99
u/l
—
5
29
11
80
1.38
0.38
1.2
1.2
—
—
—
0
0
9
67
1.35
0.38
1.7
2.8
—
—
—
0
0
29
341
0.84
0.35
1.2
1.1
0.92
0.72
ratio
—
5
31
160
1508
1.08
0.35
3.6
3.9
47.93
64.72
mg/l
0.61
118
1046
22
181
1.22
0.35
2.2
1.9
5.30
5.37
iu/ml
—
7
45
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
6
46
1.31
0.33
1.2
1.4
—
—
—
0
0
62
684
0.90
0.32
3.8
3.5
236.52
156.64
ug/g
0.90
55
581
6
47
1.28
0.32
1.2
1.3
2.79
3.25
g/l
—
6
29
6
47
1.28
0.32
1.2
1.3
7.80
6.65
g/l
—
6
29
6
47
1.28
0.32
1.2
1.3
0.31
0.37
g/l
—
6
29
29
249
1.17
0.31
1.2
1.7
—
7.73
—
0
11
31
357
0.86
0.31
1.2
1.1
1.31
1.41
g/l
2.09
31
357
19
157
1.22
0.30
1.1
1.1
—
—
—
0
0
13
103
1.27
0.28
1.1
1.1
3.64
16.36
au/ml
—
5
45
32
364
0.87
0.28
1.2
1.1
0.98
0.93
g/l
0.45
32
364
226
2175
1.06
0.28
2.0
1.9
1.62
1.51
mmol/l
0.92
189
1900
67
616
1.10
0.27
2.6
3.3
4.13
4.29
e9/l
0.20
53
546
5
75
0.66
0.26
1.4
5.0
—
—
—
0
0
6
83
0.72
0.24
1.0
1.3
—
—
—
0
0
84
896
0.93
0.23
1.5
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
69.82
—
0
11
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
45
412
1.10
0.21
1.6
1.8
0.45
0.33
mg/l
0.45
24
229
0
13
0.00
0.21
0.0
1.1
—
36.98
—
0
13
0
14
0.00
0.20
0.0
1.1
—
0.81
—
0
8
22
193
1.14
0.20
1.3
1.3
195.00
175.94
miu/ml
—
9
76
12
99
1.22
0.19
1.1
1.2
11.49
15.34
u/l
0.56
12
88
204
1980
1.04
0.18
2.8
2.5
71.85
71.11
nmol/l
0.13
186
1838
7
60
1.17
0.18
1.3
1.6
40.57
111.23
mu/l
—
7
47
18
158
1.14
0.16
1.1
1.1
—
—
—
0
0
68
643
1.06
0.16
1.7
1.6
—
—
—
0
0
72
683
1.06
0.15
1.5
1.6
3.93
3.62
mmol/l
0.88
43
459
20
223
0.89
0.14
1.4
1.6
—
—
—
0
0
477
4815
0.97
0.13
4.6
4.4
6.00
5.98
mmol/l
0.11
434
4496
159
1547
1.04
0.13
4.3
4.6
8.07
10.20
mg/mmol
0.32
106
1053
22
202
1.09
0.10
1.7
2.0
0.00
3.47
estimate
—
7
73
93
902
1.04
0.09
1.8
1.8
429.20
32041758.42
pmol/l
0.97
74
774
10
87
1.15
0.09
1.0
1.2
—
—
—
0
0
5
48
1.04
0.09
1.0
1.0
1438.80
1531.13
miu/ml
—
5
48
32
302
1.06
0.08
2.4
2.1
6.10
6.09
ph
0.02
21
190
5
61
0.82
0.08
2.6
2.7
11.60
10.70
mmol/l
—
5
61
43
412
1.05
0.07
1.1
1.1
—
—
—
0
0
39
375
1.04
0.06
1.2
1.2
—
—
—
0
0
114
1122
1.02
0.04
3.2
3.3
1.02
1.02
kg/l
1.40
73
702
15
140
1.07
0.04
1.7
2.4
62.62
124.94
ug/min
—
10
80
32
308
1.04
0.04
8.8
8.6
24.44
24.44
mmol/l
0.00
32
294
11
101
1.09
0.04
1.3
1.2
—
—
—
0
0
14
133
1.05
0.01
5.0
1.4
1.31
1.16
g/l
0.95
14
126
14
133
1.05
0.01
5.0
1.4
0.27
0.23
g/l
0.66
14
126
184
1834
1.00
0.00
3.6
4.1
9.35
9.25
mmol/l
0.08
152
1620
21
215
0.98
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
1.91
—
0
8
0
8
0.00
0.00
0.0
6.9
—
7.38
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
0.82
—
0
9
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.05
—
0
5
22
220
1.00
-0.00
1.2
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
13.77
—
0
5
5
49
1.02
-0.00
1.2
1.3
86.20
87.45
umol/l
—
5
49
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
15.00
—
0
9
0
7
0.00
-0.00
0.0
1.1
—
275.43
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_TESTIS – Malignant neoplasm of testis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).